Differential Effects of Isoflurane and Propofol Anesthesia on Neurogenesis in Young and Aged Rats by Erasso, Diana Marcela
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
2011
Differential Effects of Isoflurane and Propofol
Anesthesia on Neurogenesis in Young and Aged
Rats
Diana Marcela Erasso
University of South Florida, derasso@health.usf.edu
Follow this and additional works at: http://scholarcommons.usf.edu/etd
Part of the American Studies Commons, and the Neurosciences Commons
This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.
Scholar Commons Citation
Erasso, Diana Marcela, "Differential Effects of Isoflurane and Propofol Anesthesia on Neurogenesis in Young and Aged Rats" (2011).
Graduate Theses and Dissertations.
http://scholarcommons.usf.edu/etd/3092
  
 
Differential Effects of Isoflurane and Propofol Anesthesia  
on Neurogenesis in Young and Aged Rats 
 
by 
 
Diana M. Erasso 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
Department of Pathology and Cell Biology 
College of Medicine  
University of South Florida 
 
 
Co-Major Professor: Samuel Saporta, Ph.D. 
Co-Major Professor: Enrico M. Camporesi, M.D. 
Paula Bickford, Ph.D. 
Jay Dean, Ph.D. 
David Diamond, Ph.D. 
 
 
Date of Approval: 
April 4, 2011 
 
 
 
Keywords: postnatal neurogenesis, isoflurane, propofol, cognitive impairment 
 
Copyright  2011, Diana M. Erasso 
 
 
 
 
     
 
DEDICATION 
I dedicate my dissertation to my family and friends. A special feeling of gratitude to my 
mother, Nubia Agudelo, my grandmother Carmen Amira Bustamante, and my aunt Clara 
Berolo whose words of love, concern, support and encouragement have helped me 
throughout my graduate student career. 
I also dedicate this work and give special thanks to my fiancé Carlos Felipe Chaves, who 
was always encouraging me and stood by me through the good and bad times. His 
support and encouragement was in the end what made this dissertation possible. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
ACKNOWLEDGMENTS 
I owe my gratitude to all those people who have made this dissertation possible and 
because of whom my graduate experience has been one that I will cherish forever. I 
would like to express my deepest gratitude to my two co-major professors, Dr. Samuel 
Saporta, for his excellent guidance, caring, and patience and Dr. Enrico Camporesi, for 
his patience, encouragement and support. I will also like to thank Dr. Don Cameron for 
his insightful comments and for kindly allowing me to use his laboratory equipment. I 
wish to thank my committee members, Dr. Paula Bickford, Dr. Jay Dean, and Dr. David 
Diamond, who were more than generous with their expertise and precious time. A special 
thank to Dr. Huafeng Wei, my committee chairman. Many thanks to my laboratory 
members, Dr. Rafael Chaparro, Dr. Carolina Quiroga Del Rio, and Dr. Rachel Karlnoski 
for their help and support. My research would not have been possible without their helps. 
 
 
 
 
 
 
 i 
 
 
 
 
 
TABLE OF CONTENTS 
 
 
 
LIST OF FIGURES .............................................................................................................v 
ABSTRACT .................................................................................................................... vi 
INTRODUCTION ...............................................................................................................1 
 Evidence of adverse effects of general anesthetics on the developing brain ..........2 
 Evidence of adverse effects of general anesthetics on the senescence brain ...........4 
 Postnatal neurogenesis in the context of learning and memory ...............................7 
 The process of postnatal neurogenesis .....................................................................7 
 Regulation of postnatal neurogenesis ......................................................................9 
 General anesthetics ................................................................................................10 
 Conclusion .............................................................................................................11 
 References cited .....................................................................................................12 
 
 
CHAPTER 1: QUANTITATIVE ASSESSMENT OF NEW CELL  
PROLIFERATION IN THE DENTATE GYRUS AND BEHAVIOR AFTER 
ISOFLURANE OR PROPOFOL ANESTHESIA IN YOUNG AND AGED  
RATS .................................................................................................................................19 
 Abstract ..................................................................................................................19 
 Introduction ............................................................................................................21 
 Materials and Methods 
  Animals ......................................................................................................22 
  Isoflurane anesthesia ..................................................................................23 
  Propofol anesthesia ....................................................................................23 
  BrdU injections ..........................................................................................23 
  Cognitive assessment .................................................................................24 
  Tissue preparation and BrdU immunohistochemistry ...............................25 
  Microscopy ................................................................................................25 
  Statistical analysis ......................................................................................26 
 Results 
  Physiologic parameters ..............................................................................26 
  New cell proliferation in the DG of young rats is decreased by  
 ii 
  isoflurane anesthesia ..................................................................................26 
  New cell proliferation in the DG of young rats is decreased by  
  propofol anesthesia ....................................................................................27 
  The number of BrdU+ cells in the olfactory bulb is not altered by  
  either isoflurane or propofol anesthesia .....................................................27 
  Isoflurane causes cognitive impairment in aged rats .................................27 
  Propofol causes cognitive impairment in young rats .................................28 
 Discussion 
  Effect of isoflurane and propofol on new cell proliferation 
  in the brain .................................................................................................28 
  Effect of isoflurane and propofol anesthesia on cognitive function ..........30 
  Conclusion .................................................................................................31 
  References cited .........................................................................................32 
 
 
CHAPTER 2: THE INHALATION ANESTHETIC ISOFLURANE AFFECTS 
NASCENT CELLS UNDERGOING MATURATION AND SYNAPTIC 
INTEGRATION IN THE DENTATE GYRUS OF AGED, BUT NOT YOUNG 
RATS ................................................................................................................................44 
 Abstract ..................................................................................................................44 
 Introduction ............................................................................................................46 
 Materials and Methods 
  Animals ......................................................................................................47 
  Experiment timeline ...................................................................................47 
  Preparation and administration of thymidine analogs ...............................48 
  Isoflurane anesthesia ..................................................................................49 
  Measurement of physiological parameters during isoflurane  
  anesthesia ...................................................................................................49 
  Tissue collection and processing ...............................................................49 
  CldU and IdU immunohistochemistry .......................................................50 
  EdU labeling protocol ................................................................................50 
  Double immunohistochemistry for linage markers....................................51 
  Ki67 immunohistochemistry ......................................................................51 
  Tunnel assay protocol ................................................................................52 
  Microscopy and cell counting ....................................................................53 
  Statistical analysis ......................................................................................53 
 Results 
  Physiological parameter during isoflurane anesthesia ...............................54 
  Postnatal proliferation in the dentate gyrus, as assed by the ki67  
  marker is unaffected by isoflurane anesthesia ...........................................54 
  Isoflurane does not affect nascent cells undergoing differentiation  
  in the DG of the hippocampus at the time of exposure..............................55 
  Isoflurane does not affect nascent cells undergoing migration  
  in the DG of the hippocampus at the time of exposure..............................55 
  Isoflurane affects nascent cells undergoing maturation and synaptic 
  integration in the DG of aged, but not young rats......................................56 
 iii 
  Cell death in the dentate gyrus after isoflurane exposure ..........................57 
 Discussion 
  Isoflurane has an age dependent effect on postnatal neurogenesis ............58 
  Isoflurane specifically affects nascent cells undergoing maturation 
  and synaptic Integration in the DG of aged rats ........................................59 
 References cited .....................................................................................................62 
 
 
CHAPTER 3: PROPOFOL ANESTHESIA AFFECTS NASCENT CELLS 
UNDERGOING DIFFERENTIATION, AXON/DENDRITE TARGETING  
AND MIGRATION IN THE DENTATE GYRUS OF YOUNG BUT NOT  
AGED RATS ....................................................................................................................73 
 Abstract ..................................................................................................................73 
 Introduction ............................................................................................................75 
 Materials and Methods 
  Animals ......................................................................................................76 
  Experiment timeline ...................................................................................76 
  Preparation and administration of thymidine analogs ...............................77 
  Propofol anesthesia ....................................................................................78 
  Measurement of physiological parameters during propofol 
  anesthesia ...................................................................................................78 
  Tissue collection and processing ...............................................................78 
  CldU and IdU immunohistochemistry .......................................................79 
  EdU labeling protocol ................................................................................79 
  Double immunohistochemistry for linage markers....................................80 
  Ki67 immunohistochemistry ......................................................................80 
  Tunnel assay protocol ................................................................................81 
  Microscopy and cell counting ....................................................................82 
  Statistical analysis ......................................................................................82 
 Results 
  Physiological parameter during propofol anesthesia .................................83 
  Postnatal proliferation in the dentate gyrus, as assed by the ki67  
  marker is unaffected by propofol anesthesia .............................................83 
  Nascent cells undergoing differentiation in the DG of young, but  
  not aged rats, are affected by propofol anesthesia .....................................84 
  Nascent cells undergoing migration in the DG are altered by  
  propofol anesthesia in young, but not in aged rats.....................................84 
  Nascent cells undergoing maturation, in the DG of young and  
  aged rats, are unaffected by propofol anesthesia .......................................85 
  Cell death in the DG after propofol anesthesia ..........................................85 
 Discussion 
  Propofol anesthesia has a specific effect on the young brain ....................86 
  Nascent cells undergoing differentiation and migration, in the DG  
  of young rats, at the time of anesthetic exposure are particularly  
  affected by propofol ...................................................................................86 
  Nascent cells in the DG of young and aged rats seem to be affected  
 iv 
  by anesthetics in an agent-dependent manner ............................................87 
 References cited .....................................................................................................89 
 
 
 
CONCLUSIONS................................................................................................................98   
 Introduction ............................................................................................................98 
 The process of postnatal neurogenesis ...................................................................99 
 Age-dependent vulnerability to anesthetic-induced cognitive dysfunction  ........100 
 Agent-dependent effects on postnatal neurogenesis ............................................101 
 Conclusion ...........................................................................................................103 
 References Cited ..................................................................................................104 
 
ABOUT THE AUTHOR ....................................................................................... End Page 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 v 
 
 
 
 
 
 
 
 
 
 
LIST OF FIGURES 
 Figure 1: Postnatal neurogenesis stages .............................................................18 
 Figure 2: Immunohistochemical labeling of proliferating cells  
   within the DG .....................................................................................37 
 Figure 3: New cell proliferation in the DG of young rats is decreased by  
   isoflurane anesthesia ...........................................................................38 
 Figure 4: New cell proliferation in the DG of young rats is decreased by  
   propofol anesthesia .............................................................................39 
 Figure 5: The number of BrdU+ cells in the olfactory bulb is not altered  
   by isoflurane .......................................................................................40 
 Figure 6: The number of BrdU+ cells in the olfactory bulb is not altered  
   by propofol anesthesia ........................................................................41 
 Figure 7: Isoflurane causes cognitive impairment in aged rats ..........................42 
 Figure 8: Propofol causes cognitive impairment in young rats .........................43 
 Figure 9: Experimental design ...........................................................................66 
 Figure 10: Physiological parameters during isoflurane exposure ........................67 
 Figure 11: Neural progenitor cell proliferation is unaffected by isoflurane ........68 
 Figure 12: The number and fate of 4-day-old nascent cells in the DG  
  Are unaffected by isoflurane exposure ...............................................69 
 Figure 13: Cells undergoing maturation, at 8 days after birth, are  
  unaffected by isoflurane exposure in young and aged rats ................70 
 Figure 14: Isoflurane exposure affected cells that underwent maturation 
  And started to integrate in the DG of aged, but not young rats ..........71 
 Figure 15: Cell death in the DG after isoflurane exposure ..................................72 
 Figure 16: Experimental design ...........................................................................91 
 Figure 17:  Rats physiological parameters during propofol exposure ..................92 
 Figure 18:  Neural progenitor cell proliferation is unaffected by propofol ..........93 
 Figure 19:  The number and fate of 4 days-old nascent cells in the DG are  
    altered by propofol anesthesia in young, but not in aged rats ............94 
 Figure 20: Cells undergoing maturation in the DG at 8 days after birth are  
    altered by propofol anesthesia in young, but not in aged rats.  ..........95 
 Figure 21:  Propofol anesthesia does not alter nascent cells that underwent  
      maturation and starting to integrate in the DG of young  
   or aged rats .........................................................................................96 
 Figure 22:  Cell death in the DG after propofol anesthesia ..................................97 
 vi 
 Figure 23:  Summary diagram of the results .......................................................107 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
 
 
 
 
 
ABSTRACT 
 
 Worldwide, millions of young and elderly patients receive procedures that could 
not be performed without the use of anesthetics.  Unfortunately, emerging animal and 
human data suggest an association between exposure to general anesthesia and 
impairment of cognitive function in pediatric and geriatric patients. Recent laboratory 
data have shown that general anesthetics are potentially damaging to the developing and 
aging brain. However, the mechanism by which this happens is still unknown. General 
anesthetics affect learning and memory, a brain function involving neural plasticity. An 
important form of neural plasticity receiving attention is postnatal neurogenesis. This 
process is highly regulated and involved in hippocampal functions under physiological 
conditions. This dissertation hypothesizes that anesthetic induced alteration of postnatal 
neurogenesis may explain the cognitive impairment observed in some pediatric and 
geriatric patients after anesthesia. In order to accurately address this hypothesis, in the 
first portion of this dissertation, an animal model is used to examine the effects of two 
different anesthetics on cognition and new cell proliferation in young and aged rats. 
Furthermore, the second and third portion of this dissertation emphasizes on the effects of 
 viii 
these two widely used anesthetics on each of the various stage of postnatal neurogenesis 
in young and aged rats. 
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INTRODUCTION 
 Thousands of surgeries requiring anesthesia are performed every day in the 
United States. Anesthetics are among the most potent and rapidly acting drugs in 
common clinical use, and one of the greatest advances of medicine allowing complicated 
surgeries to be performed safely. Unfortunately, recent clinical and animal studies show 
that exposure to commonly used general anesthetics is associated to the development of 
cognitive impairment in pediatric (Loepke and Soriano 2008; Wilder et al. 2009) and 
geriatric patients (Moller et al. 1998a; Monk et al. 2008). 
The brain appears to be particularly vulnerable to insults that would go unnoticed at a 
different age, during development or aging. These insults may become evident as 
impairment of cognitive function. Cognitive changes associated with general anesthesia 
include impaired spatial orientation, learning and memory, but the mechanism by which 
this happens still not known. Spatial learning and memory are considered hippocampal 
cognitive domains, although other brain areas may contribute as well. An important 
determinant of hippocampal function is the degree to which new neurons are generated 
from stem cells in the subgranular zone of the dentate gyrus (DG) of the hippocampus 
(Kempermann 2002; Zhao et al. 2008; Jessberger et al. 2009; Coras et al. 2010). 
Furthermore, postnatal hippocampal neurogenesis has been shown to be altered by factors 
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such as environmental changes (Kempermann et al. 1997) and modulations of 
neurotransmitters (Sun et al. 2009). Because anesthetics also affect these factors, it seems 
reasonable to hypothesize that anesthetics may also affect postnatal hippocampal 
neurogenesis, and that its alteration may explain cognitive impairment in pediatric and 
geriatric patients. 
Evidence of adverse effects of general anesthetics on the developing brain 
 Emerging human and animal data suggest an association between early exposure 
to anesthetics and long-term impairment of cognitive function, raising concerns regarding 
the safe use of these drugs in young children. Consequently, the prudence of frequent 
anesthesia exposure of this population is now being scrutinized. 
  Current animal data implicate not only N-methyl-d-aspartate (NMDA) receptor 
antagonists, but also drugs that potentiate γ-aminobutyric acid (GABA) receptors, as 
potentially neurotoxic to the developing brain (Olney et al. 2000; Young et al. 2005). 
Drugs that act as (NMDA) receptor antagonists, like ketamine, and those that act in the 
(GABA) receptor such as benzodiazepines, induce neuronal injury and neuronal cell 
death in the brains of young rodents. Drugs that have effects on one or both of these 
receptors include barbiturates, benzodiazepines, inhaled anesthetics such as isoflurane 
and nitrous oxide, and intravenous anesthetics such as propofol and ketamine. Not all of 
these drugs have been approved for pediatric use, but they are commonly used in this 
young population. 
 In neonatal animal models, isoflurane has been associated with apoptotic 
neurodegeneration (Yon et al. 2005; Lu et al. 2006). In rats, a 6-hour exposure to an 
anesthetic combination of isoflurane, midazolam, and nitrous oxide, a commonly used 
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combination for long pediatric surgical procedures, has been shown to induce widespread 
apoptotic neurodegeneration in newborn animals, and impairment in learning and 
memory later in adulthood. Neither nitrous oxide nor midazolam alone produced 
neuroapoptosis. In contrast, administration of isoflurane alone caused neuroapoptosis 
(Jevtovic-Todorovic et al. 2003). The combination of isoflurane and midazolam produced 
a substantial increase in the number of apoptotic cells, and the triple combination of 
isoflurane, midazolam, and nitrous oxide produced the greatest increase in the number of 
neuroapoptotic cells. Animals treated with the “triple combination” also demonstrated 
persistent memory and learning impairments later in life, which correlated with deficits in 
hippocampal synaptic function measured electrophysiologically in vitro (Jevtovic-
Todorovic et al. 2003). Preliminary data in neonatal rats from another research group also 
suggest that isoflurane, when administered for 4 hours as a single anesthetic drug, alters 
fear conditioning and spatial learning in adulthood (Stratmann 2006). 
 Another widely used general anesthetic used for pediatric surgical procedures is 
the intravenous anesthetic, propofol. However, the effects of propofol administration on 
neuronal survival and neurocognitive performance have not been formally studied in 
young children. A study of the effects of propofol on neuronal structure and 
neurocognitive performance in mice suggests that propofol exposure during brain 
development increases neurodegeneration, and results in cognitive deficits in adulthood 
(Fredriksson et al. 2007). Using in vitro preparations of neuronal cell cultures from 
immature chicks and rats, several investigators noted a dose-dependent neuronal 
structural change after propofol exposure (Honegger and Matthieu 1996; Spahr-Schopfer 
et al. 2000; Vutskits 2005). Supraclinical doses of propofol induced neuronal cell death in 
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dissociated cell culture models, but failed to demonstrate neurotoxic effects in 
organotypic slice cultures (Spahr-Schopfer et al. 2000). Furthermore, exposure of 
dissociated neurons to propofol in clinically relevant concentrations for up to 3 days did 
not result in dendritic development changes. In conclusion, no prospective studies have 
examined the effects of propofol on neuronal structure and neurocognitive outcome in 
young children, whereas several case reports detail short-term neurological abnormalities 
without long-term neurocognitive impairment. However, detailed follow-up has not been 
conducted in this patient population. A study in neonatal mice points to propofol’s dose-
dependent neurodegenerative properties, leading to behavioral and learning 
abnormalities, which are exacerbated by the co-administration of ketamine. Animal 
studies using in vitro preparations demonstrate only subtle changes, whereas current 
evidence fails to reveal injurious effects of propofol on neuronal survival and dendritic 
development. 
Evidence of adverse effects of general anesthetics on the aging brain 
 According to the 2004 US census, people over eighty years of aged are the fastest 
growing segment of the population, this population grew 30% over the previous decade 
(Bureau 2004). Therefore, elders are one of the largest group receiving anesthetics. 
Patients over sixty-four years of age have eight-fold more procedures per 10000 people 
than patients fifteen years of age or younger, and more than two-fold more than patients 
aged 45-64 years old. Moreover, the aging brain becomes more susceptible to 
neurodegeneration over time. In other words, the aging brain has less reserve and small 
adverse events may have a greater impact on brain function. 
 In 1998 Moller et al presented the first of a series of multicenter studies on 
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cognitive dysfunction after anesthesia. The study included 1,218 patients, aged 60 yr or 
older, who underwent major abdominal, non-cardiac thoracic, or orthopedic surgery 
during general anesthesia. Patients were tested preoperatively, and at 1 week and 3 
months postoperatively. Test results were compared with a total of 321 controls recruited 
from the United Kingdom, 11 centers in Europe, and 2 centers in North America. Patients 
were classified as experiencing cognitive dysfunction when two Z scores in individual 
tests declined by 1.96, or the combined average Z score declined greater than 1.96. At 1 
week postoperatively, 25.8% of 1,011 patients experienced a decline in cognitive 
function, compared with 3.4% of 176 control subjects. At 3 months postoperatively, 9.9% 
of 910 patients experienced a decline relative to preoperative level of function, compared 
with 2.8% of controls (Moller et al. 1998b). 
 A number of subsequent studies have described cognitive impairment within the 
first 10 days after surgery and anesthesia (Dodds and Allison 1998). Williams-Russo et al 
found a rate of cognitive dysfunction of 5% at 6 months after surgery, although in the 
absence of a control population, the significance is hard to determine (Williams-Russo et 
al. 1995). A follow-up study that evaluated patients at 1 and 2 yr found that the rate of 
cognitive dysfunction decreased to approximately 1%, which was not statistically 
significant (Abildstrom et al. 2000). Taken together, it seems that elderly patients 
manifest measurable deterioration shortly after surgery and anesthesia (25% at 2–10 
days), with gradual resolution such that the incidence declines (10% at 3 months, 5% at 6 
months, 1% at 1 yr) to levels nearly indistinguishable from control subjects by 
approximately 1 yr. In one study, less than half of the participants who were classified at 
having cognitive impairment at 3 months had detectable decline at 1 week. Consequently 
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cognitive impairment at 1 week did not predict cognitive impairment at 3 months, 
(Rasmussen and Siersma 2004) 
 A large clinical study from Duke University now appears to confirm earlier 
findings, in the 1998 study (Moller et al. 1998b), showing that significant number of 
elderly people experience long term (three or more months) changes in cognitive function 
after anesthesia (Monk et al. 2008). One thousand sixty four patients were classified as 
young (18-39 years old), middle aged (40-59 years old) or elderly (60 years old or older). 
Their cognitive function was assessed with a battery of tests before surgery, at discharge 
from the hospital, and 3 months after the discharge. At the discharge form the hospital, 
signs of cognitive impairment were present in 30-41% of patients. At the 3-month time 
point, young and middle aged patients had recovered, but 12.7% of elderly patients still 
showed cognitive impairment. Moreover, patients with cognitive dysfunction were more 
likely to die in the year after surgery. 
 In the laboratory, Culley et al. (2003) found that 2 hours of anesthesia with 1.2% 
isoflurane/70% nitrous oxide/30% oxygen produces long-lasting, but reversible 
impairment on a previously learned spatial memory task in 18-mo-old-rats. Additionally, 
when the same aged animals were exposed to the same concentration of anesthetic for the 
same period of time, but the spatial memory task performed two weeks after anesthesia, 
the aged rats subject to general anesthesia were less able than control rats to perform well 
(Culley et al. 2004a). 
 The aging brain appears to be more susceptible to anesthetic effects than the adult 
brain. This may be due to the several ways in which they are different, including size, 
distribution and type of neurotransmitters, metabolic function, capacity for plasticity, and 
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inflammation, suggesting that the senescent brain may be more susceptible to anesthetic 
changes. 
Postnatal neurogenesis in the context of learning and memory 
 General anesthesia has been implicated as a possible cause of cognitive 
impairment. Laboratory data shows that spatial memory is impaired by general 
anesthetics in aged rats (Culley et al. 2003). Spatial memory is considered a hippocampal 
cognitive domain, even though other areas contribute to spatial learning and memory. An 
important determinant of hippocampal function in animals is the degree to which new 
neurons are generated from stem cells in the subgranular zone of the dentate gyrus (DG) 
of the hippocampus. Neurogenesis in the DG decreases progressively with age (Luo et al. 
2006; Shruster et al. 2010), but both a decrease in the levels of the stress hormone 
corticosterone (Mirescu et al. 2004) and environmental enrichment (Kempermann et al. 
1997) can restore neurogenesis and improve spatial memory function. Thus, cognitive 
impairment following anesthetic exposure may be a result of anesthetic-induced 
alteration of postnatal neurogenesis. 
The process of postnatal neurogenesis 
 Neurogenesis is the process of generating functionally integrated neurons from 
progenitors cells. It was traditionally believed to occur only during the embryonic stage 
(Ramon 1913). However, studies of Altman and Das (Altman 1962; Altman and Das 
1965) provided the first indication that new neurons are generated in the postnatal 
mammalian brain. More recently, it has been recognized that postnatal neurogenesis 
replicates the complex process of neurodevelopment in order to generate functional 
integrated neurons important for learning and memory. Postnatal neurogenesis in 
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mammals is primarily restricted to two brain regions: the subventricular zone (SVZ) of 
the lateral ventricles and the subgranular zone (SGZ) of the hippocampal DG. Neural 
stem cells proliferate and give rise to new granule cells through the following 
developmental stages: proliferation, differentiation, migration, maturation and synaptic 
integration (Figure 1) (Ming and Song 2005). These stages can be identified on the basis 
of cell morphology, mitotic capability, electrophysiology characteristics, and expression 
of developmental regulated markers (Kempermann et al. 2004). Proliferating SVZ cells 
form a migrating chain and differentiate into neurons in the olfactory bulb (Alvarez-
Buylla and Garcia-Verdugo 2002; Lazarini and Lledo 2011). Postnatal hippocampal 
progenitor cells divide in the SGZ and develop into neurons in the granular cell layer. 
Nascent cells become functionally integrated into the DG and have passive membrane 
properties, action potentials and functional synaptic inputs similar to those found in 
mature dentate granule cells (Snyder et al. 2005). Newly generated neurons play a 
significant role in synaptic plasticity (Ming and Song 2005; Snyder et al. 2005) and the 
reduction in the number of these cells impairs learning and memory (Shors et al. 2002). 
Neurotransmitters, growth factors, hormones and environmental factors are among the 
mediators involved in the regulation of adult hippocampal neurogenesis (Kempermann 
2002). GABAergic receptor agonists and NMDA receptor antagonists induce dentate 
gyrus progenitor proliferation with increased newborn neurons in the granule cell layer 
(Cameron et al. 1995). Enriched environments result in more total granule cell neurons 
by increasing the survival rate of the progeny of the dividing progenitor cells 
(Kempermann et al. 1997) On the other hand, impaired hippocampal neurogenesis may 
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be associated with cognitive decline in aging, major depression and Alzheimer’s disease 
(Haughey et al. 2002; Tsuchiya et al. 2003; Raber et al. 2004). 
 Neural Stem Cells (NSCs) generate significant numbers of progenity in young 
rats, with approximately 9000 new cells or 0.1% of the granular cell population being 
replaced daily (Cameron and McKay 2001). Approximately 50% of the neuronal 
progenity survive, and new granule cells populate the inner third of the granular cell 
layer. Postnatal neurogenesis is not a one-step process, as new neurons have to progress 
through several distinct developmental steps before they fully integrate and eventually 
become indistinguishable from granule cells born during embryonic or early postnatal 
development (Laplagne et al. 2006).  
Regulation of postnatal neurogenesis 
 The basic rate of neurogenesis in the DG is thought to be genetically determined 
(Cameron and McKay 2001), but it can be regulated by a variety of factors such as 
physical activity (van Praag et al. 1999), environmental enrichment (Kempermann et al. 
1997), stress (Kempermann et al. 1997; Mirescu et al. 2004), gender, steroids (Tanapat et 
al. 1999), inflammation (which reduces the number of newborn cells) (Tanapat et al. 
1999; Monje et al. 2003), and aging (Seki and Arai 1995; Kuhn et al. 1996; Tanapat et al. 
1999; Luo et al. 2006; Lazarov et al. 2010). There is an exponential decrease of 
neurogenesis throughout the life span in rodents, non-human primates and potentially 
humans (Galvan and Jin 2007; Lazarov et al. 2010). With advancing age, the proliferative 
activity of hippocampal NSCs and neuronal differentiation capacity decline, leading to a 
dramatic, approximately 10 fold reduction in net neurogenesis between the age of 2 
months and 2 years in a rodent’s life (Kuhn et al. 1996; Kempermann et al. 2002) 
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 Recently, the amino acid γ-aminobutyric acid (GABA) has emerged as a key 
regulator that controls multiple phases of adult neurogenesis. GABA serves as a feedback 
regulator of neural production and migration (Bordey, 2007). GABAergic mechanisms 
regulate differentiation and the timing of synaptic integration (Ge et al. 2007a). 
General anesthetics 
 General anesthetics are essential to present day medicine, but a detailed 
understanding of their mechanism of action is still absent. Nevertheless, progress has 
been made in understanding their mechanism at the molecular and cellular levels. 
Different molecular targets in various regions of the nervous system are involved in the 
multiple components of anesthetic action. General anesthetic agents range from inhaled 
anesthetics, such as isoflurane, desflurane, sevoflurane, nitrous oxide and xenon, to 
intravenous anesthetics, such as propofol, ketamine, and benzodiazepines. Even though, 
these agents are chemically different, their proposed mechanism of action is thought to 
affect synaptic transmission by altering GABA and N-methyl-d-aspartate (NMDA) 
receptors (Campagna 2003).  
 Neurotransmitter-gated ion channels, particularly receptors for γ-amino butyric 
acid (GABA) and glutamate, are modulated by most anesthetics at both synaptic and 
extra synaptic sites. General anesthetics act as either positive or negative allosteric 
modulators of ligand-gated ion channels at clinically effective concentrations (Hemmings 
et al. 2005). Most inhaled anesthetics enhance GABA receptor function, increasing 
channel opening to enhance inhibition at both synaptic and extra synaptic receptor. In 
addition they appear to depress excitatory synaptic transmission presynaptically, where 
their principal action seems to be a reduction in glutamate release. Most intravenous 
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anesthetics, including propofol, selectively modulate GABA receptor function by 
enhancing gating of the receptors by GABA. Because GABA and NMDA mediated 
neuronal regulation is essential for postnatal neurogenesis, exposure to general 
anesthetics could potentially interfere with the neurogenic process and ultimately result in 
cognitive impairment. 
Conclusion 
 In summary, increasing clinical and laboratory data have raised significant 
concerns regarding the safety of general anesthetics used on young and old individuals. 
General anesthetics have been implicated as a possible cause of cognitive impairment, 
because surgery in pediatric and geriatric patients often involves general anesthesia. 
General anesthesia has also been shown to impair spatial memory in rats (Culley et al. 
2004a; Culley et al. 2004b). One of the factors involved in spatial memory is postnatal 
neurogenesis. Alteration of neurogenesis may be a possible reason for the cognitive 
impairment experienced in some pediatric and geriatric patients after general anesthesia. 
Moreover, neurogenesis is a multistep process, and alteration of one or more of these 
stages may result in subtle, but adverse consequences. The effect of anesthesia on the 
different stages of neurogenesis is not known. We hypothesize that alteration of 
neurogenesis by anesthesia may explain the cognitive impairment observed in some 
pediatric and geriatric patients. 
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POSTNATAL NEUROGENESIS STAGES 
 
 
 
 Figure 1. Postnatal neurogenesis, a developmental process that includes 
proliferation and fate speciﬁcation of adult neural stem cells along with their 
differentiation, maturation, migration and incorporation into the existing neural circuitry 
of their progeny in the mature nervous system. 
 
 
 
Modified from Ming GL, Song H (2005) Adult neurogenesis in the mammalian central 
nervous system. Annu Rev Neurosci 28: 223-250 
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CHAPTER 1 
QUANTITATIVE ASSESSMENT OF NEW CELL PROLIFERATION IN THE 
DENTATE GYRUS AND BEHAVIOR AFTER ISOFLURANE OR PROPOFOL 
ANESTHESIA IN YOUNG AND AGED RATS 
 
 
Abstract 
 Background: There is a growing body of evidence showing that a statistically 
significant number of people experience long-term changes in cognition after anesthesia. 
We hypothesize that this cognitive impairment may result from an anesthetic-induced 
alteration of adult hippocampal cell proliferation. 
 Methods: To test this hypothesis, we investigated the effects of isoflurane and 
propofol on new cell proliferation and cognition of young (4 month-old) and aged (21 
month-old) rats that were anesthetized for 3 hours with either 1.5% isoflurane or 
35mg/kg/hr propofol. An additional group of young and aged rats exposed to room air or 
intralipid, served as controls. All rats were injected intraperitoneally (IP) with 50 mg/Kg 
of 5-bromo-2-deoxyuridine (BrdU) immediately after anesthesia. A novel appetitive 
olfactory learning test was used to assess learning and memory two days after anesthesia. 
One week after anesthesia, rats were euthanized and the brains analyzed for new cell 
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proliferation in the dentate gyrus, and migration of newly formed cells in the 
subventricular zone to the olfactory bulb. 
 Results: We found that exposure to either isoflurane (p=0.017) or propofol 
(p=0.006) decreased hippocampal cell proliferation in young, but not in aged rats. This 
anesthetic-induced decrease was specific to new cell proliferation in the hippocampus, as 
new cell proliferation and migration to the olfactory bulb was unaffected. Isoflurane 
anesthesia produced cognitive impairment in aged rats (p=0.044), but not in young rats. 
Conversely, propofol anesthesia resulted in cognitive impairment in young (p=0.01) but 
not in aged rats. 
 Conclusions: These results indicate that isoflurane and propofol anesthesia affect 
postnatal hippocampal cell proliferation and cognition in an age dependent manner. 
 
 Keywords: isoflurane, propofol, cognitive impairment, new cell proliferation, 
cognition. 
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Introduction 
 Since its introduction to medical practice, anesthetic agents have enabled 
surgeries to be performed with ease, ensuring analgesia, unconsciousness and amnesia. 
Nonetheless, growing clinical and laboratory data suggest that anesthetic agents have 
long lasting consequences that may lead to cognitive impairment (Moller et al. 1998a; 
Monk et al. 2008) particularly in elderly and pediatric patients. 
 Ten to fifteen percent of elderly patients suffer from difficulties with 
concentration and attention after anesthesia (Moller et al. 1998b). Furthermore, recent 
studies suggest an association between early exposure to general anesthesia and long-
term impairment of cognitive function in pediatric patients (Wilder et al. 2009). This 
phenomenon has been observed in animal models. Culley and colleagues (2004a, 2004b) 
reported enduring deficits in spatial working memory of aged rats after exposure to 
isoflurane, nitrous oxide, or isoflurane-nitrous oxide anesthesia (Culley et al. 2004a; 
Culley et al. 2004b). Similarly, young rats exposed to isoflurane show persistent memory 
and learning deficits (Jevtovic-Todorovic et al. 2003; Culley et al. 2004a; Zhang et al. 
2008). 
 Postnatal generation of neurons occurs throughout life and has been clearly 
demonstrated in two brain regions, the subgranular zone (SGZ) of the dentate gyrus (DG) 
in the hippocampus and the subventricular zone (SVZ) of the lateral ventricle where new 
neurons migrate into the olfactory bulb (OB) (Altman and Das 1965; Eriksson et al. 
1998; Gage 2002; Ming and Song 2005; Taupin 2006a; Taupin 2006b). This process is 
more pronounced during early postnatal life and decreases with age (Galvan and Jin 
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2007; Lazarov et al. 2010), which may make new cell proliferation at these time periods 
more susceptible to insults. Postnatal neurogenesis in the DG has been shown to be 
involved in learning and memory (Kempermann 2002; Shors et al. 2002; Zhao et al. 
2008; Jessberger et al. 2009). However, the effects of anesthetics on neurogenesis are not 
well understood, raising concerns regarding the effect of certain anesthetic agents on 
cognition. 
 In this study, we investigated whether isoflurane and/or propofol affected learning 
and new cell proliferation in the brain of young and aged rats shortly after administration 
of anesthesia. We hypothesized that cognitive impairment following anesthesia may 
result from an anesthetic-induced alteration of hippocampal new cell proliferation. 
Evaluation of new cell proliferation immediately following anesthesia constitutes the first 
step for a more extensive study of the effects of anesthesia on neurogenesis. 
 
Materials and Methods 
 All experiments were conducted in accordance with the National Institute of 
Health Guide and Use of Laboratory Animals, and were approved by the Institutional 
Animal Care and Use committee of the University of South Florida, College of Medicine, 
Tampa, Fl. 
 Animals: to evaluate the effects isoflurane and propofol on the developing and 
aging brain, rats of two different ages were used for this study: 4-month old (young) and 
21-month old (aged) male Fischer-344 rats (Harlan Sprague Dawley, Indianapolis, IN). 
All rats were acclimated and handled for two weeks prior to the beginning of the 
experimental procedures. 
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 Isoflurane Anesthesia: one cohort of rats was randomly assigned to four 
different groups (n=12 per group): young rats exposed to 1.5% isoflurane delivered in 2 
L/min O2 via nose cone for 3 hours, young rats exposed to a mixture of air and 2 L/min 
O2 in the cage for 3 hours, aged rats exposed to 1.5% isoflurane delivered in 2 L/min O2 
via nose cone for 3 hours, and aged rats exposed to a mixture of air and 2 L/min O2 in the 
cage for 3 hours. Isoflurane (Forane, Ohmeda Caribe, NJ, USA) was delivered via a 
standard anesthesia vaporizer. Perioperiative parameters such as body temperature, 
oxygen saturation and heart rate were measured throughout the anesthesia period. Body 
temperature of rats was maintained at 37°C with a thermostatically controlled heating 
pad. 
 Propofol Anesthesia: a separate cohort of rats was randomly assigned to four 
different groups breathing air (n=10 per group): young rats that received 35 mg/kg/hr of 
propofol or 10% intralipid (control) for 3 hrs, and aged rats that received 35 mg/kg/hr of 
propofol or 10% intralipid for 3 hours. Unanesthetized rats were placed in a restrainer 
and a tail vein catheter was implanted and attached to a syringe pump (model 11 Plus; 
Harvard Apparatus). Propofol (Disoprivan; AstraZeneca) or 10 % intralipid (Fresenius 
Kabi; Sweden) that served as control was continuously administered for 3 hours. Body 
temperature of rats was maintained at 37°C with a thermostatically controlled heating 
pad. 
 BrdU Injections: to evaluate the effects of isoflurane and propofol on new cell 
proliferation in the brain, 5-Bromo-2-deoxyuridine (BrdU; Sigma-Aldrich Munich, 
Germany) was injected intraperitoneally at a dose of 50 mg/kg in all groups immediately 
following the anesthesia or control procedure and 18 hours after the first injection. 
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 Cognitive assessment: cognitive function was assessed using a task that requires 
the rats to make odor-reward associations using foraging for palatable food, which results 
in rapid acquisition with minimal stress and fear (Eichenbaum 1998). Rats performed the 
novel odor discrimination task two days after exposure to either isoflurane or propofol 
anesthesia. Rats were initially habituated to a 97 cm2 black Plexiglas box, and shaped to 
receive treats in the box. Rats were food deprived the night prior to behavioral testing. 
Two odors were presented in adjacent corners of the box. A treat was placed next to one 
odor while the second odor was not paired to a reward (Fortin et al. 2002). The rat was 
placed in the middle of the box facing away from the odors and reward and allowed to 
explore the novel odors and find the reward. The position of the odor/reward pair was 
randomized between trials. Each rat received ten learning trials (120 seconds cut off). 
Each rat received one test trial, which assessed accuracy of memory and time to reach the 
reward. An Etho Vision computerized tracking and movement analysis system (Noldus 
Information Technology) was used to record and collect behavioral data. Due to technical 
difficulties with the tracking system, number of errors and time spent on each corner 
during the olfactory task was only recorded for young rats exposed to either propofol or 
intralipid. A blinded individual performed the behavioral experiment, and all equipment 
used for behavioral testing was wiped with 70% ethanol between animal uses to eliminate 
olfactory trails. 
 Tissue preparation and BrdU immunohistochemistry: one week after 
anesthesia, rats were deeply anesthetized with pentobarbital (50 mg/kg, i.p.) and 
transcardially perfused with 100 ml saline. Brains were removed, and immersion fixed in 
4% paraformaldehyde for 5 days, and then placed in 20% sucrose. Frozen sagittal 
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sections (30 μm) through the entire DG were collected serially. Sections were pretreated 
with 50% formamide/2X Saline-Sodium Citrate (SSC) at 65°C for 2 hours, rinsed in 2X 
(SSC), incubated in 2N HCL for 30 minutes at 37°C, and then washed with borate buffer 
(pH 8.5), followed by phosphate buffered saline (PBS). Subsequently, endogenous 
peroxidase activity was quenched with 3% H2O2 solution in PBS. Sections were blocked 
for 1 hour in 3% normal horse serum and 0.25% Triton X-100 in PBS (PBS-TS). 
Sections were incubated overnight with mouse-anti-rat-BrdU (1:100; Roche) in PBS-TS. 
The following day, sections were washed in PBS, incubated for one hour in biotinylated 
secondary antibody (horse anti-mouse IgG rat adsorbed 1:200; Vector Laboratories, 
Burlingame, CA) in PBS-TS, and washed in PBS before incubation for 1 hour in avidin-
biotin substrate (ABC kit, Vector Laboratories, Burlingame, CA). Sections were washed 
in PBS for 10 minutes and reacted with 3,3´- diaminobenzidine tetrahydrochloride (DAB) 
solution (Thermo Scientific, Rockford, IL). Sections were then mounted onto glass slides, 
dehydrated, and coverslipped with mounting medium (Cytoseal 60,Stephens Scientific, 
Riverdale)(Bachstetter et al. 2010). 
 Microscopy: unbiased stereological methods were used to estimate the numbers 
of BrdU labeled cells (BrdU+) in the subgranular zone of the DG. Twelve equally spaced 
sections throughout the medial-lateral extent of the DG were collected. Because BrdU+ 
cells are a rare event, the number of BrdU+ cells in each DG examined was summed for 
individual animals and the sum from each animal was then multiplied by the section 
spacing to estimate the total number of BrdU+ cells (Mouton 2002). These data were then 
used to calculate group means for estimates of total BrdU+ cells. Labeled cells that were 
greater than 1 cell diameter away from the subgranular layer were not included in the 
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count (Figure 2). Only cells that had a clearly defined nuclear outline, with speckled or 
solid labeling over the nucleus, were considered BrdU positive. BrdU+ cells were 
visualized using a bright field microscope by an individual blinded to the treatment of the 
animals. 
 Statistical analysis: statistical analysis was performed using a two-way analysis 
of variance (ANOVA) for repeated measurements followed by a Tukey’s post-hoc test. 
All results are presented as the mean ± SEM. Statistical comparison of the data was 
performed using GraphPad Prism version 5.00 for Mac (GraphPad Software, San Diego 
California USA, www.graphpad.com) 
 
Results 
 Physiological parameters: perioperiative variables were recorded every thirty 
minutes during the anesthesia procedure. Body temperature of the rats was maintained at 
37°C. Oxygen saturation averaged 85% and 86%, respectively, for aged and young rats 
exposed to propofol, and 94% and 95%, respectively, for aged and young rats exposed to 
isoflurane. Heart rate averaged 327 and 340 beats per minute, respectively, for aged and 
young rats exposed to propofol, and 297 and 328 beats per minute, respectively, for aged 
and young rats exposed to isoflurane. 
 New cell proliferation in the DG of young rats is decreased by isoflurane  
anesthesia: figure 3 shows new cell proliferation assessed immediately after isoflurane 
anesthesia. A two-way Analysis of Variance ANOVA (F3, 27= 67.39; p= 0.017) revealed 
that, when compared to the control group, isoflurane anesthesia significantly decreased 
the number of BrdU+ cells in the subgranular zone (SGZ) of the DG of young rats. There 
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was not a statistical difference in the number of BrdU+ cells between aged rats exposed 
to isoflurane and aged control rats (p= 0.084). As previously reported (Seki and Arai 
1995; Garcia et al. 2004; Luo et al. 2006; Lazarov et al. 2010), we found a decrease in 
new cell proliferation in aged, as compared to young, rats (p< 0.0001). 
 New cell proliferation in the DG of young rats is decreased by propofol  
anesthesia: new cell proliferation was assessed immediately after propofol anesthesia 
(Figure 4). A two-way ANOVA (F3, 30= 51.13; p= 0.006) revealed that, when compared 
to the group exposed to intralipid, propofol anesthesia significantly decreased the number 
of BrdU+ cells in the DG of young rats. There was not a statistical difference in the 
number of BrdU+ cells between aged rats exposed to propofol and aged rats exposed to 
intralipid (p= 0.181). We also found a decrease in new cell proliferation in aged, as 
compared to young, rats (p< 0.0001) as expected. 
 The number of BrdU+ cells in the olfactory bulb is not altered by either 
isoflurane or propofol anesthesia: to assess whether anesthesia produced an overall 
decline in cell proliferation, the number of BrdU+ cells was counted in the granular and 
glomerular cell layer of the olfactory bulb (Figure 5 and Figure 6). No significant 
difference was found in the number of BrdU+ cells in the glomerular or granule cell 
layers in rats exposed to either propofol or isoflurane anesthesia when compared with 
controls. However, a decrease in new cell proliferation in aged, as compared to young 
rats (p< 0.0001) was found. 
 Isoflurane causes cognitive impairment in aged rats: cognitive function was 
assessed two days after rats were exposed to isoflurane (Figure 7). Data were analyzed 
using a two-way ANOVA with repeated measures and revealed that young rats learned 
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the task (p<0.0001). Aged rats also acquired the task (p<0.0001), though not as rapidly as 
young rats. Aged rats exposed to isoflurane showed a deficit in learning, as compared to 
the aged rats that served as controls exposed to room air (F3, 38= 21.11; p= 0.044). 
Learning in young rats exposed to isoflurane was not impaired as compared to the young 
control group (p= 0.495). 
 Propofol causes cognitive impairment in young rats: cognitive function was 
assessed two days after rats were exposed to propofol (Figure 8). Data were analyzed 
using a two-way ANOVA with repeated measures and revealed that young rats learned 
the task (p<0.0001). Aged rats also acquired the task (p<0.0001), though not as rapid as 
young rats. Young rats exposed to propofol showed a deficit in learning, as compared to 
other groups (F3, 40= 17.58; p= 0.01). Learning in the aged group exposed to propofol was 
not impaired when compared to the aged control group (p= 0.067) (Figure 8A). 
Moreover, young rats exposed to propofol were making significantly more errors than 
young controls (F1, 12= 6.49; p= 0.026) (Figure 8B). When examining the amount of time 
spent in the correct vs. the incorrect corner (Figure 8C), it was found that young rats 
exposed to propofol were spending significantly more time in the incorrect corner as 
compared to young controls (F3, 296= 4.71; p= 0.0038). 
 
Discussion 
 Effect of isoflurane and propofol on new cell proliferation in the brain: our 
study reveals three interesting results. First, as previously reported (Seki and Arai 1995; 
Garcia et al. 2004; Luo et al. 2006; Lazarov et al. 2010), we found a decrease in new cell 
proliferation in aged rats compared to young rats, in both neurogenic regions. With 
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increasing age, there is a dramatic decline in subventricular zone and DG cell 
proliferation.  
 Second, three hours of isoflurane or propofol anesthesia affect DG cell 
proliferation immediately after anesthesia in young rats, while new cell proliferation in 
the DG of aged rats is unaffected, suggesting an age dependent susceptibility. Cell 
proliferation in the young DG, although occurring at the higher rate, seems more 
susceptible to propofol and isoflurane anesthesia than DG cell proliferation in the aged 
brain (Shruster et al. 2010). Similar studies by other groups have shown an alteration of 
DG cell proliferation in P60 and P7 rats after 4 hours of isoflurane anesthesia (Stratmann 
et al. 2009).  
 Third, we found that while isoflurane or propofol anesthesia resulted in a decrease 
in the number of Brdu+ cells in the DG of young rats, the number of Brdu+ cells in the in 
the granular and glomerular cell layer of the olfactory bulb (OB) was unaffected. In this 
study, we wanted to examine whether the anesthetic agent effect was confined to the DG 
or if there was a generalized effect on progenitor cell proliferation in the brain with 
anesthesia. We found that isoflurane and propofol seem to have a specific effect on the 
DG. New cell proliferation in the DG may be more susceptible to disruption by 
anesthetics than new cell proliferation in the SVZ. For example, a reduction in new cell 
proliferation in the SGZ, but not in the SVZ has been reported after low-dose irradiation 
of the heads of adult rodents (Tada et al. 2000; Mizumatsu et al. 2003; Snyder et al. 
2005). 
 Few studies have focused on DG cell proliferation with propofol anesthesia. 
Studies report no alterations in cell proliferation after 6 hours of propofol via jugular vein 
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catheter and 100 mg/kg of BrdU given intraperitoneally (Lasarzik 2006). Similarly, a 
study in which young and middle-aged Sprague Dawley rats received one of four 
anesthetics (propofol, isoflurane, dexmedetomidine, and ketamine) for 8 hrs and received 
200 mg/Kg BrdU during the anesthetic period found no effect of the anesthetics on DG 
cell proliferation (Tung et al. 2008). The discrepancies between these studies and ours 
may be due to differences in the rat strain (F344 vs. Sprague Dawley), the timing of the 
anesthetic (6 hrs vs. 3 or 4 hrs), the dose of BrdU (100, 200 or 50 mg/Kg), or timing of 
the BrdU injection (before, during or following anesthesia). 
 Effect of isoflurane and propofol anesthesia on cognitive function: cognitive 
impairment has been observed in aged rats (18-20 month old) following exposure to 
anesthesia using the 12-arm radial arm maze. When studying the effect of anesthesia on 
old memory retrieval, aged rats were impaired while adult rats improved their 
performance (Culley et al. 2003). On the other hand, when animals were tested for new 
memory formation 2 weeks after exposure to anesthesia, aged animals were impaired 
(Culley et al. 2004a) while adult animals (6 month old) showed no impairment (Crosby et 
al. 2005). In our study, aged animals in the control group took less time to find the reward 
than aged animals exposed to isoflurane even though both groups learned the task. Aged 
animals in the isoflurane group took more time to reach the reward and made more errors 
during the task than aged control animals. Therefore, learning was delayed by the 
anesthetic. When looking at the effect of isoflurane on cognition on young animals under 
the same testing conditions, we found that cognitive function is unaffected by isoflurane 
exposure. Our study, supports previous findings of cognitive impairment after isoflurane 
anesthesia (Culley et al. 2003; Culley et al. 2004a; Culley et al. 2004b)  
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 Propofol is widely used among pediatric and geriatric patients. However, there are 
few studies on its effect on cognitive function in an animal model. In one study, propofol 
anesthesia in aged rats (18 month old) did not affect spatial memory assessed by the 12-
arm-radial maze (Lee et al. 2008). Similarly, in our study, propofol anesthesia had no 
effect on cognition in aged rats using the olfactory association task. However, we found 
that, similar to isoflurane, propofol had an age dependent effect, though opposite to that 
found with isoflurane. Propofol caused cognitive impairment in young animals. 
 Conclusion: in summary, we found that isoflurane and propofol anesthesia 
produce cognitive impairments as assessed by our olfactory behavioral paradigm that are 
age, and agent dependent. The effect on progenitor cell proliferation is age dependent and 
selective to the dentate gyrus. Furthermore, propofol in young animals impairs learning 
and decreases progenitor cell proliferation. This study is the basis for more detailed 
studies on the effect of these two anesthetic agents on the process of neurogenesis. 
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 Figure 2. Immunohistochemical labeling of proliferating cells within the dentate 
gyrus (DG) with bromodeoxyuridine (A) 4 month-old propofol (B) 4 month-old intralipid 
(C) 21 month-old propofol (D) 21 month-old intralipid. 
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 Figure 3. New cell proliferation in the DG of young rats is decreased by 
isoflurane anesthesia. Number of BrdU+ cells in the dentate gyrus (DG) of young (4 
month-old) and aged (21 month-old) rats, after 3 hours of 1.5% isoflurane anesthesia 
(isoflurane) or no isoflurane (control). There is a statistically significant difference between 
young control and young isoflurane-exposed rats (*p= 0.0171), but not a statistically 
significant difference in the aged groups. 
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 Figure 4. New cell proliferation in the DG of young rats is decreased by 
propofol anesthesia. Number of BrdU+ cells in the dentate gyrus (DG) of young (4 month-
old) and aged (21 month-old) rats, after 3 hours of 35 mg/Kg/hr of propofol anesthesia 
(propofol) or 35 mg/kg/hr *p= 0.0171.of 10% intralipid (intralipid). There is a statistically 
significant difference between young intralipid and young propofol-infused rats (*p=0.0062), 
but there is not difference in the aged groups. 
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 Figure 5. The number of BrdU+ cells in the olfactory bulb is not altered by 
isoflurane. Number of BrdU+ cells in the granular and glomerular cell layer of the olfactory 
bulb (OB) of young (4 month-old) and aged (21 month-old) rats, after 3 hours of 1.5% 
isoflurane anesthesia (isoflurane) or no isoflurane (control). There was not a statistically 
significant difference between the controls and the isoflurane-exposed rats. 
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  Figure 6. The number of BrdU+ cells in the olfactory bulb is not altered by 
propofol anesthesia. Number of BrdU+ cells in the granular and glomerular cell layer of 
the olfactory bulb (OB) of young (4 month-old) and aged (21 month-old) rats, after 3 hours 
of 35 mg/Kg/hr of propofol anesthesia (propofol) or 35 mg/kg/hr of 10% intralipid 
(intralipid). There was not a statistically significant difference between the controls and the 
isoflurane-exposed rats. 
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 Figure 7. Isoflurane causes cognitive impairment in aged rats. This graph 
shows the average time to find reward during the olfactory learning test of young (4 month-
old) and aged (21 month-old) rats 7 days after 3 hours of 1.5% isoflurane anesthesia 
(isoflurane) or no isoflurane (control). Animals were tested on the behavioral paradigm two 
days following isoflurane anesthesia. Aged rats also acquired the behavioral task (p<0.0001), 
though not as rapid as young rats. Learning in aged animals was impaired by isoflurane (*p= 
0.0443).  
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 Figure 8. Propofol causes cognitive impairment in young rats. Rats were tested 
on the behavioral paradigm two days following propofol anesthesia. (A) This graph shows 
the average time to find reward during the olfactory learning test of young (4 month-old) and 
aged (21 month-old) rats 7 days after 3 hours of 35 mg/Kg/hr of propofol anesthesia 
(Propofol) or 35 mg/kg/hr of 10% intralipid (intralipid). Aged rats also acquired the 
behavioral task (p<0.0001), though not as rapid as young rats. Learning in young rats was 
impaired by propofol (*p=0.0099). (B) This graph shows the number of errors made by 
young rats exposed to either propofol or intralipid during the olfactory learning test. Young 
rats exposed to propofol made significantly more errors than young controls (p=0.026). (C) 
Time spent in correct vs. incorrect corner of young rats exposed to either propofol or 
intralipid. Young rats exposed to propofol spent significantly more time in the incorrect 
corner than young rats exposed to intralipid (*p= 0.0038). In addition, young rats exposed to 
propofol spent significantly more time in the incorrect vs. the correct corner (**p=0.0167). 
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CHAPTER 2 
THE INHALATION ANESTHETIC ISOFLURANE AFFECTS NASCENT CELLS 
UNDERGOING MATURATION AND SYNAPTIC INTEGRATION IN THE 
DENTATE GYRUS OF AGED, BUT NOT YOUNG RATS 
 
 
Abstract 
 Background: Worldwide, volatile anesthetics are used in millions of young and 
elderly patients. Nevertheless, recent studies on human and animals suggest that 
anesthesia early or late in life may cause cognitive impairment, the mechanism of which 
is still unknown. Postnatal hippocampal neurogenesis is involved in learning and memory 
(Culley et al. 2004a; Coras et al. 2010), and an anesthetic-induced alteration of postnatal 
neurogenesis may, in part, explain the cognitive impairment observed after anesthesia. 
This study asserts the effects of isoflurane on neurogenesis. Even though, the majority of 
studies focus on the effects of isoflurane on postnatal neurogenesis after the exposure, 
this study concentrates on the effects of isoflurane on the undergoing neurogenesis at the 
time of exposure. 
 Methods: 1.5% isoflurane in 2L/min O2 was administered via nose cone for 3 
hours to 3-month-old and 20 month-old F344 rats. Three different thymidine analogs 
(CldU, IdU, and EdU) were intraperitoneally injected at three different time points (21 
days, 8 days, and 4 days, respectively) prior to isoflurane or control exposure in order to 
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assess integration, maturation and differentiation of nascent cells in the dentate gyrus 
(DG) at the time of isoflurane anesthesia. Moreover, phenotype identification at each 
time point was assessed by co-localization of each thymidine analog with the 
corresponding histological marker for each stage of neurogenesis. TUNEL assay was also 
performed to assess cell death in the DG after isoflurane. 
 Results: In this study, isoflurane did not affect any stage of postnatal 
neurogenesis in young rats. Even though, no differences were detected on hippocampal 
progenitor proliferation, nascent cell differentiation, or migration and axon dendrite 
targeting of nascent cells in the hippocampus of aged rats, isoflurane significantly 
decreased the number of nascent cells that were in the process of integration at the time 
of exposure (p=0.022) only in the aged rats. Additionally, it was found that in aged rats; 
isoflurane significantly reduced neuronal production (p=0.008), while astrocyte 
production was significantly increased (p=0.003). A significant effect of isoflurane on 
cell death was not found.  
 Conclusion: These results suggest an age and stage dependent effect of 
isoflurane. Because isoflurane anesthesia appears to be particularly harmful to the aged 
brain, especially to nascent cells undergoing maturation and synaptic integration in the 
dentate gyrus of the hippocampus. 
 
 Keywords: isoflurane, cognitive impairment, postnatal neurogenesis, cognition 
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Introduction 
 Increasing clinical and laboratory findings suggest long-term or even permanent 
impairment of cognitive function following the administration of an anesthetic drug 
(Moller et al. 1998; Loepke and Soriano 2008). A commonly used agent to induce and 
maintain general anesthesia is the inhaled anesthetic isoflurane, which is widely used in 
various types of surgery in pediatric and geriatric patients. Isoflurane is thought to 
produce its effects by acting as a γ-aminobutyric acid (GABA) agonist and a N-methyl-d-
aspartate (NMDA) receptor antagonist. Recent laboratory data indicate that isoflurane 
exposure induces neurodegeneration in newborns (Jevtovic-Todorovic et al. 2003; Li et 
al. 2007), and that anesthesia exposure during development is a significant risk factor for 
impairment of cognitive function later in life (Wilder et al. 2009). Additionally, Culley et 
al. found that in 18-mo-old rats, anesthesia for 2h with 1.2% isoflurane/nitrous 
oxide/oxygen produces long lasting, but reversible impairment on a new and on 
previously learned spatial memory task (Culley et al. 2003; Culley et al. 2004a). Spatial 
memory is considered to be a hippocampal cognitive domain (Snyder et al. 2005). An 
important determinant of hippocampal function is postnatal generation of neurons 
throughout life in certain areas of the brain, particularly the dentate gyrus (DG) of the 
hippocampus, and the subventricular zone (SVZ) of the lateral ventricle (Eriksson et al. 
1998; Gage 2002; Coras et al. 2010). Postnatal neurogenesis is more pronounced early in 
life and decreases with age (Luo et al. 2006; Galvan and Jin 2007; Lazarov et al. 2010). 
Even though prior studies label neurogenic cells after isoflurane exposure (Tung et al. 
2008; Stratmann et al. 2010), this study considers it important to label neurogenic cells 
prior to isoflurane exposure, in order to study its effects on each stage of postnatal 
 47 
neurogenesis. Postnatal neurogenesis is not a one step but a multi step process that 
involves the proliferation of progenitors, differentiation and maturation of the nascent 
cells, and the incorporation of these cells into the existing circuit. And an alteration of 
one or more of these stages may result in cognitive dysfunction.  
 
Material and Methods 
 Animals: all experiments were conducted in accordance with the National 
Institute of Health Guide and Use of Laboratory Animals, and were approved by the 
Institutional Animal Care and Use committee of the University of South Florida, College 
of Medicine. Male Fisher 344 (F344) rats (Harlan Sprague Dawley, Indianapolis, IN), 
were pair-housed in environmentally controlled conditions (12:12h light: dark cycle at 
21±1°C) and provided food and water ad lib. Rats of two age groups were used in this 
study, young (3 months-old) and aged (20 months-old). Rats were excluded from the 
study if they became jaundiced, or had abdominal tumors. 
 Experimental timeline: three different thymidine analogs (CldU, IdU, and EdU) 
were intraperitoneally injected at three different time points (21 days, 8 days, and 4 days, 
respectively) prior to the anesthetic or control exposure in order to assessed integration, 
maturation and differentiation of nascent cells in the dentate gyrus (DG) at the time of 
isoflurane anesthesia. Moreover, phenotype identification at each time point was assessed 
by co-localization of each thymidine analog with the corresponding histological marker 
for each neurogenic stage. Quantification of co-localization of CldU and the mature 
neuronal marker NeuN or the astrocytic marker S100β assessed nascent cells undergoing 
synaptic integration at the time of isoflurane anesthesia. Quantification of co-expression 
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of IdU and the immature neuronal marker DCX or the astrocytic marker S100β assessed 
nascent cells undergoing migration and axon/dendrite targeting. Furthermore, by 
determining co-localization of EdU with the immature neuronal marker DCX or the 
astrocytic marker S100β nascent cells undergoing differentiation were assessed. Lastly, 
nascent cells proliferation was assessed using the endogenous marker Ki67. Labeling of 
each neurogenic stage was performed in the same animal (Figure 9). 
 Preparation and administration of thymidine analogs: solutions of 5-Chloro-
2’-deoxyuridine (CldU) and 5-Iodo-2’-Deoxyuridine (IdU) were prepared at equimolar 
concentrations. CldU (Sigma #C6891) was prepared at 17 mg/ml and IdU (MP#100357) 
at 23 mg/ml. Injections at 2.5 ml/Kg resulted in an equimolar final effective delivery of 
42.5 mg/Kg CldU or 57.5 mg/Kg IdU, as previously described (Vega and Peterson 2005). 
Both halogenated thymidine analog solutions were prepared in sterile saline and 
administered by intraperitoneal (IP) injection to ensure precise delivery to facilitate 
quantitative comparisons. Because cell division is a rare event in the subgranular zone of 
elderly rats and because many of these newborn cells do not survive, we were concerned 
that a short thymidine analog labeling protocol would not yield a new cell number 
sufficient for a meaningful analysis. Therefore, three times the thymidine analog 
corresponding to a specific time point was administered; three IP injections at 4-hour 
intervals in one day were given. As shown in Figure 9, animals in all groups were 
injected with CldU, 21 days before control or isoflurane exposure; and IdU, 8 days before 
control or isoflurane exposure. 
 A solution of 5-ethynyl-2’-deoxyuridine (EdU) was prepared at a concentration of 
60 mg/ml in sterile saline. IP injections of EdU (cat #. E10187, Invitrogen, Carlsbad, CA) 
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resulted in a final effective delivery of 160 mg/Kg., Animals in all groups were injected 
only once with EdU, 4 days before isoflurane anesthesia (Figure 9). 
 Isoflurane anesthesia: after a two week acclimation period to the vivarium under 
standard conditions, rats were randomly assigned to four different groups (n=8 per 
group): young rats exposed to 1.5% isoflurane delivered in 2 L/min O2 via nose cone for 
3 hours, young rats exposed to a mixture of air and 2 L/min O2 in the cage for 3 hours, 
aged rats exposed to 1.5% isoflurane delivered in 2 L/min O2 via nose cone for 3 hours, 
and aged rats exposed to a mixture of air and 2 L/min O2 in the cage for 3 hours. 
Isoflurane (Forane, Ohmeda Caribe, NJ, USA) was delivered via a standard anesthesia 
vaporizer. Body temperature of rats was maintained at 37°C throughout the anesthesia 
period with a thermostatically controlled heating pad.  
 Measurement of physiological parameters during isoflurane anesthesia: 
rectal temperature was monitored throughout the exposure and recorded every 30 minutes 
using a thermalet-monitoring thermometer (Physitemp instrument Inc, Clifton, NJ, USA). 
Moreover, hemoglobin oxygen saturation (SpO2) and heart rate (HR) were recorded 
every 30 minutes using the SurgiVet multi-parameter monitor (Smiths medical, Dublin, 
OH, USA). Diastolic, systolic and mean arterial pressures were measured every 30 
minutes throughout the anesthesia period by tail cuff using the CODA non- invasive 
blood pressure system for rats (CODA2, Kent Scientific Corporation). 
 Tissue collection and processing: twenty-four hours after control or isoflurane 
exposure, rats were deeply anesthetized with pentobarbital (50 mg/ Kg, i.p) and 
transcardially perfused with 100 ml saline followed by ice-cold 4% paraformaldehyde in 
0.1M PBS. Brains were removed, postfixed in the same fixative solution at 4°C 
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overnight, transferred to 20% sucrose in PBS until equilibrated, and then frozen in 
Tissue-Tek OCT before cryostat sectioning. Sagittal cryosections (30 µm thick) through 
the entire DG were collected serially, transferred to a cryoprotectant solution, and stored 
at -20°C until used. These sections were used to assess proliferation and phenotypic 
determination of nascent cells in the DG. All standard staining procedures were 
conducted on free-floating sections using every twelfth section through the entire 
hippocampus beginning with a random start and including sections before and after the 
hippocampus to ensure that the entire structure was sampled. 
 CldU and IdU immunohistochemistry: sections were washed three times for 10 
min in PBS before being treated with 0.2N HCL for 10 min at 37°C for DNA denature to 
facilitate antibody access, sections were then washed with borate buffer (pH 8.5), 
followed by three washes of PBS. Sections were then incubated in 5% normal goat serum 
and 0.25% Triton X-100 in PBS (PBS-TS) for 60 min, and stained at 4°C. Detection of 
halogenated thymidine analogs was accomplished using rat anti-BrdU (Accurate cat# 
OBT-0030; clone BU1/75) at 1:250 for CldU and mouse anti-BrdU (Becton Dickinson 
cat# 347580; clone B44) at 1:500 for IdU. All secondary antibodies were used at 1:300 
and were conjugated to the fluorophore Alexa 594 or Alexa 488. 
 EdU labeling protocol: EdU labeling was performed using Click-iTTM EdU 
imaging kit cat # C10339 (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
protocol. This protocol is normally intended for use in cell culture, but was adapted for 
histological staining of brain tissue. Sagittal cryosections (30 µm thick) were washed 
three times for 10 min in PBS. After washing twice with 3% bovine serum albumin 
(BSA) in PBS, sections were permeablized with 0.5% Triton X-100 in PBS for 20 min. 
 51 
Sections were then washed twice with 3% BSA in PBS and incubated with the Click-
iTTM reaction cocktail (CuSO4, Alexa Fluor 594 Azide, and manufacture’s reaction 
buffer additive) for 30 min while protected from light. Sections were washed one more 
time with 3% BSA in PBS, mounted onto glass slides, and coverslipped with Vectashield 
mounting medium for fluorescence (cat# H-1000 Vector Laboratories, Burlingame, CA, 
USA). 
 Double immunohistochemistry for lineage markers: the phenotypes of CldU, 
IdU and EdU labeled cells were determined using double immunofluorescent staining. 
Antibodies against doublecortin (DCX), neuronal nuclei (NeuN) and S100β were used to 
detect immature neurons, mature neurons and astrocytes, respectively. DNA 
denaturation, followed by incubation of the primary antibodies for CldU and IdU was 
performed as described above. A rabbit polyclonal goat antibody raised against human 
DCX (1:200 cat# 4604 Cell Signaling technology, Inc. Danvers, MA, USA) was used in 
an antibody cocktail with the IdU antibody to assess immature neurons. A mouse 
monoclonal antibody against neuronal nuclei, NeuN (MAB377 Millipore, Billerica, MA, 
USA) was used at a concentration of 1:500 in an antibody cocktail with the CldU 
antibody to assess mature neurons. A rabbit monoclonal goat antibody raised against 
S100β (ab52642 abcam, Cambridge, MA, USA) was used at a concentration of 1:3000 in 
an antibody cocktail with CldU or IdU to assess astrocytes. 
 For double labeling of EdU/DCX and EdU/S100β EdU staining was performed 
first, followed by incubation with DCX or S100β, respectively. 
 Ki67 immunohistochemistry: Ki67 is expressed in cells G1 through M phase of 
the cell cycle (Scholzen and Gerdes 2000). For detection of Ki67, sections were 
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pretreated with 1X Saline-Sodium Citrate (SSC) at 80°C for 40 minutes. Subsequently, 
endogenous peroxidase activity was quenched with 0.6% H2O2 solution in PBS for 20 
min. Sections were blocked for 1 hour in 2% normal goat serum and 0.25% Triton X-100 
in PBS (PBS-TS). Sections were incubated overnight at 4°C with a rabbit polyclonal 
antibody against human Ki67 (NCL-Ki67p; Novocastra Laboratories/Vision BioSystems, 
Newcastle upon Tyne, UK) at a dilution of 1:2000 in PBS-TS. The following day, 
sections were washed in PBS, incubated for one hour in biotinylated secondary antibody 
(goat anti-rabbit IgG rat adsorbed 1:1000; BA-1000 Vector Laboratories, Burlingame, 
CA) in PBS-TS, and washed in PBS before incubation for 1 hour in avidin-biotin 
substrate (ABC kit cat no. PK-6100, Vector Laboratories, Burlingame, CA). Sections 
were washed in PBS for 10 minutes and reacted with 3,3´- diaminobenzidine 
tetrahydrochloride (DAB) solution (cat no.1856090, Thermo Scientific, Rockford, IL). 
Sections were then mounted onto glass slides, dehydrated, and coverslipped with 
mounting medium (Cytoseal 60,Stephens Scientific, Riverdale). 
 Tunel assay protocol: in order to determine if isoflurane had an effect on cell 
death, the in situ cell death detection kit, Fluorescein (cat no. 11684795910, Roche, 
Mannheim, Germany) was used according to the manufacturer's instructions. Sections 
were incubated with 3% bovine serum albumin in 0.1 mol/L Tris-HCL (pH 7.5) for 30 
mins followed by 50 µL of TUNEL reaction mixture on each sample for 60 mins at 37°C. 
After washing, slides were incubated with 0.3% H2O2 in methanol for 10 mins, followed 
by 3% bovine serum albumin in 0.1 mol/L Tris-HCL (pH 7.5) for 30 mins at room 
temperature. Incubation with peroxidase-conjugated anti-fluorescein (diluted 1:5) at 37°C 
for 30 mins was performed. 
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 Microscopy and cell counting: unbiased stereological methods were used to 
estimate the numbers of positive labeled cells (+ labeled cells) in the subgranular zone of 
the DG. Twelve equally spaced sections throughout the medial-lateral extent of the DG 
were collected. Because + labeled cells are a rare event, the number of + labeled cells in 
each DG examined was summed for individual animals and the sum from each animal 
was then multiplied by the section spacing to estimate the total number of +labeled cells 
(Mouton 2002). These data were used to calculate group means for estimates of total 
+labeled cells. +Labeled cells that were greater than 1 cell diameter away from the 
subgranular layer were not included in the count 
 Sections were imaged on an Olympus FV1000 laser scanning microscope with 
four laser sources: 405 Diode, multi-line Argon (for Alexa 488), green HeNe (for Alexa 
594), and red HeNe was used for all immunofluorescence photomicrographs. When 
quantification of percentage of positive cells was determined, Z stacks were created at 0.5 
µm intervals throughout the 30 µm of the sections with a guard region of 2µm excluded 
form top and bottom of the Z stack. The Z stacks were rotated in all planes to verify 
double labeling. Images of positive staining were adjusted to make optimal use of the 
dynamic range of detection.  
 Statistical analyses: data are presented as mean ± SEM. Analysis of variance 
(ANOVA) with Tukeys post hoc or a t-test was used to compare the differences from the 
control group. P-values less than 0.05 were considered statistically significant, the 
significance testing was one-tailed and GraphPad Prism version 5.00 for Mac (GraphPad 
Software, San Diego California USA, www.graphpad.com) was used to analyze the data.  
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Results 
 Physiological parameters during isoflurane anesthesia: rectal temperature was 
recorded every 30 minutes during the isoflurane exposure in young (n=8) and aged (n=8) 
rats (Figure 10A). The body temperature was between 36 and 37°C during the first hour, 
and then it increased almost 1°C and remained stable for the rest of the isoflurane 
exposure, with an average of 37±0.23 and 37±0.13 for young and aged rats, respectively. 
Mean arterial blood pressure throughout the isoflurane exposure averaged 89.45± 2.74 
and 84.8±3.50 for young and aged rats respectively (Figure 10B). Heart rate and 
hemoglobin oxygen saturation also remained stable during the 3 hours exposure (Figure 
10C). An age difference in most of the measured parameters was detected. 
 Postnatal proliferation in the Dentate Gyrus, as assessed by the Ki67 marker, 
is unaffected by isoflurane anesthesia: the effects of isoflurane exposure (1.5% for 3 
hours) on neuronal cell proliferation in the SGZ in young (3 month old) and aged (20 
month-old) F344 rats was determined by analyzing Ki-67 labeling, 24 hours after 
exposure. Figure 11A shows that Ki67 positive cells in both young and aged rats were 
primarily located on the border of the granule cell layer. Isoflurane does not appear to 
have an effect on newborn cells generated during the 24 hours after exposure (Figure 
11B). The results were subjected to a 2 (age: young, aged) X 2 (treatment: control, 
isoflurane) factorial ANOVA. There was a significant effect of age (F (3, 7) = 8.57, p 
<0.001), but no significant effect of treatment (F (3, 7) = 0.51, p = 0.818). Isoflurane 
exposure did not result in a statistically significant effect in the young (p= 0.248) nor in 
the aged rats (p=0.212).  
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 Isoflurane does not affect nascent cells undergoing differentiation in the DG 
of the hippocampus at the time of exposure: we quantified the number of newborn 
cells undergoing differentiation at the time of the isoflurane exposure by estimating the 
number of EdU positive cells. And determined the phenotype of these newly born cells 
using double labeling of EdU and the immature neuronal marker DCX (Figure 12C) and 
EdU and the astrocytic marker S100β (Figure 2.4A-B). The results were subject to a 2 
(age: young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was a 
significant effect of age (F (2,11)= 16.61, p<0.0001), but no significant effect of 
treatment (F (2,11)= 6.61, p= 0.06). We found that there was no difference in the number 
of EdU+ cells and no difference in the proportion of EdU labeled cells starting to express 
neuronal or glial phenotype at the time of isoflurane exposure in young or aged rats 
(Figure 12A-B). Our analysis revealed that 57% of the EdU labeled cells in the young 
control rats expressed DCX, indicating neuronal differentiation, while only 4.2% of the 
EdU labeled cells express S100β, indicating that they have differentiated into mature 
astrocytes. When the percentage of each phenotype was summed, it revealed a number 
less than 100%, indicating that either some of these cells were already going through 
maturation and were expressing the mature neuronal marker NeuN (not quantified at this 
time point) or they were still undefined. From a detailed study by Palmer et al. (Palmer et 
al. 2000) it is known that at early time points proliferating endothelial cells account for a 
large percentage (more than 35% in the rat model of that study) of the dividing cells. 
 Isoflurane does not affect nascent cells undergoing migration in the DG of 
the hippocampus at the time of exposure: we quantified the number of newborn cells 
undergoing maturation at the time of the isoflurane exposure by estimating the number of 
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IdU positive cells. And determined the phenotype of these newly born cells using double 
labeling of IdU and the immature neuronal marker DCX (Figure 13C) and IdU and the 
astrocytic marker S100β (Figure 2.5A-B). The results were subject to a 2 (age: young, 
aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was a significant 
effect of age (F  (7,11)= 70.18, p<0.0001), but no significant effect of treatment (F (7,11)= 
1.87, p=0.086). We found that there was no difference in the number of IdU+ cells and no 
difference in the proportion of IdU labeled cells maturating into neurons or astrocytes at 
the time of isoflurane exposure in young or aged rats (Figure 13A-B). Our analysis 
revealed that 70% of the IdU labeled cells in the young control rats expressed DCX, 
indicating neuronal maturation, while only 15% of the IdU labeled cells express S100β, 
indicating that they have differentiated into mature astrocytes. When the percentage of 
each phenotype was summed, it revealed a number less than 100%, indicating that either 
some of these cells were already going through maturation and were expressing the 
mature neuronal marker NeuN (not quantified at this time point). 
 Isoflurane affects nascent cells undergoing maturation and integration in the 
DG of aged, but not young rats: we estimated the number of newborn cells undergoing 
synaptic integration at the time of isoflurane exposure by estimating the number of CldU 
positive cells, and determined the phenotype of these newly born cells (Figure 14A-B) 
using double labeling of: CldU and the mature neuronal marker NeuN (Figure 14C), and 
CldU and the astrocytic marker S100β (Figure 2.6D). There was a significant effect of 
age (F  (7,11)= 16.48, p<0.0001), and a significant effect of treatment (F (7,11)= 1.52, 
p=0.04). Isoflurane significantly decreased the number of CldU+ cells (*p=0.02), and the 
number of CldU+/NeuN+ cells  (**p=0.008), but increased the number of 
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CldU+/S100β+ cells (***p=0.033). We found that isoflurane decreased the number of 
CldU labeled cells, neurogenesis, and astrocyte formation in the DG of aged, but not 
young rats The number of CldU-labeled cells in aged rats was 36% lower in isoflurane 
exposed rats (F (5,32)=5.74 p= 0.022), but unaffected in young rats (Figure 14C-D). 
Isoflurane exposure reduced neuronal production, as judged by CldU+/NeuN+ co-
localization, significantly in aged rats (*p= 0.008). Conversely, the number of newborn 
astrocytes increased significantly in aged rats (***p=0.033) after isoflurane exposure. 
 Cell death in the Dentate Gyrus after isoflurane exposure: cell death positive 
label in the DG was assessed by the DNA strand breaks (TUNEL Assay) in young and 
aged rats 24 hours after isoflurane exposure (Figure 15). The results were subject to a 2 
(age: young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was not 
a significant effect of age (F (2,3)= 3.90, p=0.07), and no significant effect of treatment (F 
(2,3)= 0.47, p=0.64). Isoflurane exposure did not result in a statistically significant effect 
in the young (p=0.06) nor in the aged rats (p=0.27). The number of cells positive for 
TUNEL was not different between isoflurane exposed or control rats, neither in the 
young nor in the aged groups (Figure 15). This indicates that isoflurane exposure has no 
effect on cell death in the DG.  
 
Discussion 
 The rate of neurogenesis found in this study is consistent with previous reports of 
reduced neurogenesis in aged compared with young animals (Luo et al. 2006; Shruster et 
al. 2010). The initial hypothesis of this study was that isoflurane-induced alteration of 
one or more stages of postnatal neurogenesis could in part explain the cognitive 
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dysfunction experienced in some patients after anesthesia. This hypothesis was based on 
recent laboratory data showing that isoflurane exposure early in life results in subsequent 
behavioral impairment (Jevtovic-Todorovic et al. 2003; Lu et al. 2006; Li et al. 2007; 
Loepke and Soriano 2008), and that isoflurane exposure late in life also produces 
enduring cognitive impairment (Culley et al. 2003; Culley et al. 2004a; Culley et al. 
2004b). The main findings of this study are that isoflurane causes an alteration in nascent 
cells undergoing maturation and synaptic integration in the dentate gyrus (DG) of aged, 
but not young rats. Therefore, the effects of isoflurane on postnatal neurogenesis are 
stage and age dependent.  
 Isoflurane has an age dependent effect on postnatal neurogenesis: on this 
study, isoflurane was found to be harmful to nascent cells exclusively in the DG of aged 
rats. This finding may be attributed to the fact that in general the aged brain appears to be 
particularly vulnerable to insults that would go unnoticed at a different age, and to the 
fact that with age postnatal neurogenesis exhibits a decline. The aged brain is undergoing 
the involuntary changes of senesce, and becoming more susceptible to 
neurodegeneration, with Alzheimer’s disease affecting nearly 50% of elders of 80 years 
(Xie et al. 2006) (Xie et al. 2007). Moreover, it has being shown that in the aged brain, 
NMDA receptor antagonists, such as nitrous oxide and ketamine, produce mitochondria 
swelling in cerebrocortical neurons of adult and aged rats, with the aged brain being more 
sensitive than the adult brain (Jevtovic-Todorovic and Carter 2005). In addition, 
isoflurane has been implicated in Alzheimer’s disease (Xie et al. 2006; Xie et al. 2008; 
Zhang et al. 2008). In fact, a number of studies have demonstrated enduring cognitive 
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dysfunction in aged, but not young rats anesthetized previously with isoflurane (Culley et 
al. 2004a; Culley et al. 2004b). 
 Postnatal neurogenesis exhibits an age-related decline (Seki and Arai 1995; Luo 
et al. 2006; Galvan and Jin 2007; Shruster et al. 2010), which has been associated with 
decline in hippocampal-dependent spatial memory (Snyder et al. 2005; Zhao et al. 2008a; 
Zhao et al. 2008b; Coras et al. 2010). Despite an age-related reduction in the formation of 
nascent hippocampal neurons, the neurons that are added appear functionally equivalent 
to those in young brain (Toni et al. 2008). Another study suggest that the number of 
neural stem cells does not decline with age, but that these cells rather have a decrease in 
the proliferating rate (Lugert et al. 2010) that could be due to a decreased volume of the 
vascular niche (Hattiangady and Shetty 2008). Besides the presence or absence of neural 
stem cells, the decline of neurogenesis in the aged brain might be due to a loss of 
extrinsic signals, a reduced responsiveness of the aging neural stem cells to normal 
signaling, or both. Since postnatal neurogenesis requires a specific environment, niche, 
that provides the signals needed to maintain and control the developmental stages of 
nascent cells (Ming and Song 2005). The neurogenic niche and the nascent cells form a 
functional unit that is regulated by signaling of neurotransmitters, neurotrophic factors, 
and grow factors (Palmer et al. 2000). Therefore, an age-related alteration in any of these 
signaling may account for the particularly susceptibility to isoflurane in the aged rat 
brain. 
 Isoflurane specifically affects nascent cells undergoing maturation and 
synaptic integration in the DG of aged rats: to the best of our knowledge, this is the 
first study examining the effects of isoflurane anesthesia on each one of the stages of 
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postnatal neurogenesis at the time of exposure. By using this experimental model, we 
were able to conclude that isoflurane specifically affects nascent cells undergoing the last 
neurogenic stage, maturation and synaptic integration. Even though on this current study, 
cognitive function was not assessed it may be suggested that disappearance of these cells 
has an immediate effect on cognitive function. Culley et al have consistently found 
cognitive dysfunction in aged rats up to three weeks after exposure to nitrous oxide, 
isoflurane or both (Culley et al. 2004a). However, they were not able to demonstrate 
cognitive dysfunction eight weeks after anesthetic exposure. Furthermore, Stratmann et al 
using a similar paradigm did not find cognitive dysfunction sixteen weeks after the 
anesthetic exposure (Stratmann et al. 2010).  
A possible explanation is that consistently with human data showing resolution of 
cognitive dysfunction over time. In the majority of patients diagnose one week after 
surgery, there is no evidence of cognitive dysfunction three months after surgery and the 
majority of patient diagnose at three month after do not suffer from cognitive dysfunction 
one or two years after. This is consistent with our findings, isoflurane decreased of 
nascent cells undergoing maturation and synaptic integration so disappearance of these 
cells has an immediate effect on cognitive function as seen on the clinical setting. 
 In addition, postnatal neurogenesis after the exposure may not be affected and the 
normal cycle of proliferation may be restored so that cognitive function is restored. 
 Taking together, these findings indicate that depending on the age of the 
individual, isoflurane can be either harmful or harmless. Future studies, correlating 
immunohistochemistry and behavioral assessment may clarify how isoflurane anesthesia 
 61 
may result in cognitive dysfunction in some patients and from that a way of preventing 
may be implemented. 
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 Figure 9. Experimental design. Rats in all groups were injected 21, 8, and 4 
days before isoflurane exposure, with CldU, IdU and EdU respectively. In order to study 
the effects of isoflurane on integration, maturation and differentiation of neuronal cell 
proliferation in the DG of young and aged rats  
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 Figure 10. Physiological Parameters During Isoflurane Exposure (A) Rectal 
temperature was recorded 30 mins after isoflurane induction in young (n=8) and aged 
(n=8) rats. Temperature was between 36 and 37°C during the first hour, and then it 
increased almost 1°C, and remained stable for the rest of the isoflurane exposure. (B) 
Systolic, diastolic and mean arterial blood pressures (mmHg) were also recorded every 
30 mins after isoflurane induction in young and aged rats. The blood pressure was stable 
during isoflurane inhalation. Blood pressure in the aged rats was slightly less as 
compared to the young rats. (C) Hemoglobin oxygen saturation and heart rate were also 
recorded every 30 minutes after isoflurane induction in young and aged rats, and were 
within normal limits. Data are shown as mean ± SEM. 
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 Figure 11. Neural Progenitor Cell Proliferation is Unaffected by Isoflurane 
Anesthesia (A) Shows the estimated number of Ki67 positive cells in the DG 24 hours 
after isoflurane anesthesia in young and aged rats. The results were subjected to a 2 (age: 
young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was a 
significant effect of age (F (3, 7) = 8.57, p <0.001), but no significant effect of treatment 
(F (3, 7) = 0.51, p = 0.818). Isoflurane exposure did not result in a statistically significant 
effect in the young (p= 0.248) nor in the aged rats (p=0.212). (B) Immunohistochemical 
staining for Ki67 positive cells (20X, upper image) and (40X, lower image) in DG 24 
hours after isoflurane exposure in young and aged rats. 
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Figure 12. The 
Number and Fate of 4 
days-old Newborn 
Cells in the DG are 
Unaffected by 
Isoflurane Exposure 
(A and B)  
(A) Quantification of 
EdU+ cells (right 
column), EdU+/DCX+ 
cells (middle column), 
and EdU+/S100β+ cells 
(left column) in the DG 
of young rats after 
isoflurane exposure. 
(B) Quantification of 
EdU+ cells (right 
column), EdU+/DCX+ 
cells (middle column), 
and EdU+/S100β+ cells 
(left column) in the DG 
of aged rats after 
isoflurane exposure. 
The results were 
subject to a 2 (age: 
young, aged) X 2 
(treatment: control, 
isoflurane) factorial 
ANOVA. There was a 
significant effect of age 
(F  (2,11)= 16.61, 
p<0.0001), but no 
significant effect of 
treatment (F (2,11)= 
6.61, p=0.06) (C) 
Confocal plane of the same cell, showing co-localization of EdU+ (red), DCX+ (green) 
and EdU+/DCX+ (orange) indicating differentiation into neuronal phenotype. Newly 
formed double-labeled cells were visualized using concofal microscopy in an orthogonal 
projection composed of 25 optical z-planes (0.5mm thick).  
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Figure 13. Cells 
undergoing 
maturation at 8 days 
after birth, are 
unaffected by 
isoflurane exposure in 
young and aged rats. 
(A and B)  
(A) Quantification of 
IdU+ cells (right 
column), IdU+/DCX+ 
cells (middle column), 
and IdU+/S100β+ cells 
(left column) in the DG 
of young rats after 
isoflurane exposure. 
(B) Quantification of 
IdU+ cells (right 
column), IdU+/DCX+ 
cells (middle column), 
and IdU+/S100β+ cells 
(left column) in the DG 
of aged rats after 
isoflurane exposure. 
The results were 
subject to a 2 (age: 
young, aged) X 2 
(treatment: control, 
isoflurane) factorial 
ANOVA. There was a 
significant effect of age 
(F  (7,11)= 70.18, 
p<0.0001), but no 
significant effect of 
treatment (F (7,11)= 1.87, p=0.086) (C) Confocal plane of the same cells, showing co-
localization of IdU+ (red), DCX+ (green) and IdU+/DCX+ (orange) indicating neuronal 
phenotype. Cells undergoing maturation at 8 days were visualized using concofal 
microscopy in an orthogonal projection composed of 25 optical z-planes (0.5mm thick).  
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 Figure 14. Isoflurane exposure affected cells that underwent maturation and started 
to integrate in the DG of aged, but not young rats. (A and B) Quantification of CldU+ cells 
(right column), CldU+/NeuN+ cells (middle column), and CldU+/S100β+ cells (left column) in 
the DG of young (A) and aged (B) rats after isoflurane. The results were subject to a 2 (age: 
young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. There was a 
significant effect of age (F  (7,11)= 16.48, p<0.0001), and a significant effect of treatment 
(F (7,11)= 1.52, p=0.04). Isoflurane significantly decreased the number of CldU+ cells 
(*p=0.02), and the number of CldU+/NeuN+ cells  (**p=0.008), but increased the 
number of CldU+/S100β+ cells (***p=0.033). (C) Confocal plane of the same cell, showing 
co-localization of CldU+ (green), NeuN+ (red) and CldU+/NeuN+ (orange) indicating neuronal 
phenotype. (D) Single Confocal plane of the same cell, showing co-localization of CldU (red), 
S100β+ (green) and CldU+/S100β+ (orange) indicating astrocytic phenotype. Newly formed 
double-labeled cells undergoing maturation were visualized using concofal microscopy in an 
orthogonal projection composed of 25 optical z-planes (0.5mm thick).  
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 Figure 15. Cell death in the DG after isoflurane exposure. Quantification of 
the TUNEL+ labeling in the DG of young and aged rats, 24 hours after isoflurane 
exposure. Isoflurane exposure has no effect on cell death in the DG. The results were 
subject to a 2 (age: young, aged) X 2 (treatment: control, isoflurane) factorial ANOVA. 
There was not a significant effect of age (F  (2,3)= 3.90, p=0.07), and no significant 
effect of treatment (F (2,3)= 0.47, p=0.64). Isoflurane exposure did not result in a 
statistically significant effect in the young (p=0.06) nor in the aged rats (p=0.27). 
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CHAPTER 3 
PROPOFOL ANESTHESIA AFFECTS NASCENT CELLS UNDERGOING 
DIFFERENTIATION, AXON/DENDRITE TARGETING AND MIGRATION IN 
THE DENTATE GYRUS OF YOUNG BUT NOT AGED RATS 
 
 
Abstract 
 Background: Propofol is a widely used agent for anesthetic induction and long-
term sedation, due to its favorable profile that ensures a rapid onset of action and a rapid 
recovery. However, recent clinical and laboratory studies suggest an association between 
commonly used general anesthetics and the impairment of cognitive function. In vitro 
studies suggest that propofol may be toxic to developing neurons (Honegger and 
Matthieu 1996; Vutskits 2005; Al-Jahdari et al. 2006). Therefore, we hypothesize; that 
anesthetic-induced alteration of one or more stages of postnatal neurogenesis may explain 
the impairment of cognitive function experienced by some patients. 
 Methods: 35 mg/kg/hr of propofol or 10% intralipid (control) were continuously 
infused via tail-vein catheter for 3 hours to 3 month-old and 20 month-old F344 rats. 
Three different thymidine analogs (CldU, IdU, and EdU) were intraperitoneally injected 
at three different time points (21 days, 8 days, and 4 days) prior to the anesthetic or 
intralipid infusion in order to assessed integration, maturation and differentiation of 
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nascent cells in the dentate gyrus (DG) at the time of propofol anesthesia. Moreover, 
phenotype identification at each time point was assessed by co-localization of each 
thymidine analog with the corresponding histological marker for each stage of 
neurogenesis. TUNEL assay was also performed to assess cell death in the DG after 
propofol. 
 Results: no differences were found in hippocampal progenitor proliferation, or 
neuronal synaptic integration. Nevertheless, propofol infusion significantly decreased the 
number of nascent cells that were in the process of differentiation, migration (p=0.034) 
and axon/dendrite targeting (p=0.034) only in young, but not in aged rats. In addition, we 
found that in these young rats, propofol significantly reduced neuronal differentiation, as 
judged by EdU+/ DCX+ co-localization (p=0.023). Propofol also significantly reduced 
the number of cells undergoing migration and axon/dendrite targeting, as assessed by 
IdU+/ DCX+ co-localization (p=0.047). Conversely, astrocyte production was 
significantly increased (p<0.0001). A significant increased on cell death after propofol 
infusion was not found. 
 Conclusions: These results suggest that propofol has an age and stage dependent 
effect. Because, propofol anesthesia appears to be particularly harmful to the young 
brain, especially to nascent cells undergoing differentiation, migration and axon/dendrite 
targeting. 
 
 Keywords: propofol, cognitive impairment, postnatal neurogenesis 
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Introduction 
 Due to the amount of unavoidable surgeries that pediatric and geriatric patients 
undergo daily, and to recently found evidence that suggest a relationship between 
anesthetic exposure and the development of cognitive dysfunction early and late in life. It 
is imperative to study the mechanisms by which this occurs.  
 Even though, clinically propofol has recently been related to cognitive 
dysfunction in pediatric patients (Mellon et al. 2007), in the laboratory setting not much 
attention has been given. Propofol is an intravenous anesthetic characterized by a rapid 
onset, clear emergence, and lack of cumulative effects observed in the clinical use, which 
makes it widely used for induction and maintenance of anesthesia. Despite its remarkable 
safety profile, there is emerging interest concerning side effects of propofol particularity 
in pediatric patients. Propofol has been involved in neurological sequelae in infants 
(Meyer et al. 2010) and experimental in vitro studies suggest that propofol may be toxic 
to developing neurons (Honegger and Matthieu 1996; Vutskits 2005). In vivo studies are 
needed in order to properly confirm the in vitro findings allowing us to better understand 
the clinical situation.  
 Because cognitive function is in part dependent on the generation of neurons 
throughout life, a process known as postnatal neurogenesis, which is a multistep process 
including proliferation, differentiation, and maturation of the nascent cells. An alteration 
of one or more stages of postnatal neurogenesis may results in impairment of cognitive 
function (Kempermann 2002; Dupret et al. 2008; Coras et al. 2010). Thus, it is reasonable 
to assume that an anesthetic-induce alteration of postnatal neurogenesis may explain the 
cognitive dysfunction experienced by some patients. In this study we examined the 
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effects of propofol anesthesia on each one of stages of the postnatal neurogenesis in the 
dentate gyrus of young and aged rats. 
 
Material and Methods 
 Animals: all experiments were conducted in accordance with the National 
Institute of Health Guide and Use of Laboratory Animals, and were approved by the 
Institutional Animal Care and Use committee of the University of South Florida, College 
of Medicine. Male Fisher 344 (F344) rats (Harlan Sprague Dawley, Indianapolis, IN), 
were pair-housed in environmentally controlled conditions (12:12h light: dark cycle at 
21±1°C) and provided food and water ad lib. Two age groups of animals young (3 
months-old) and aged (20 months-old) were used in this study. Animals were excluded 
from the study if they became jaundiced, or had pituitary tumors. 
 Experimental timeline: three different thymidine analogs (CldU, IdU, and EdU) 
were intraperitoneally injected at three different time points (21 days, 8 days, and 4 days, 
respectively) prior to the anesthetic or control infusion in order to assessed integration, 
maturation and differentiation of nascent cells in the dentate gyrus (DG) at the time of 
propofol anesthesia. Moreover, phenotype identification at each time point was assessed 
by co-localization of each thymidine analog with the corresponding histological marker 
for each neurogenic stage. Quantification of co-localization of CldU and the mature 
neuronal marker NeuN or the astrocytic marker S100β assessed nascent cells undergoing 
synaptic integration at the time of propofol anesthesia. Quantification of co-expression of 
IdU and the immature neuronal marker DCX or the astrocytic marker S100β assessed 
nascent cells undergoing migration and axon/dendrite targeting.  Furthermore, by 
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determining co-localization of EdU with the immature neuronal marker DCX or the 
astrocytic marker S100β nascent cells undergoing differentiation were assessed. Lastly, 
nascent cells proliferation was assessed using the endogenous marker Ki67. Labeling of 
each neurogenic stage was performed in the same animal (Figure 16). 
 Preparation and administration of thymidine analogs: solutions of 5-Chloro-
2’-deoxyuridine (CldU) and 5-Iodo-2’-Deoxyuridine (IdU) were prepared at equimolar 
concentrations. CldU (Sigma #C6891) was prepared at 17 mg/ml and IdU (MP#100357) 
at 23 mg/ml. Injections at 2.5 ml/Kg resulted in an equimolar final effective delivery of 
42.5 mg/Kg CldU or 57.5 mg/Kg IdU, as previously described (Vega and Peterson 2005). 
Both halogenated thymidine analog solutions were prepared in sterile saline and 
administered by intraperitoneal (IP) injection to ensure precise delivery to facilitate 
quantitative comparisons. Because cell division is a rare event in the subgranular zone of 
elderly rats and because many of these newborn cells do not survive, we were concerned 
that a short thymidine analog labeling protocol would not yield a new cell number 
sufficient for a meaningful analysis. Therefore, three times the thymidine analog 
corresponding to a specific time point was administered; three IP injections at 4-hour 
intervals in one day were given. As shown in Figure 16, animals in all groups were 
injected with CldU, 21 days before intralipid or propofol infusion; and IdU, 8 days before 
intralipid or propofol infusion. 
 A solution of 5-ethynyl-2’-deoxyuridine (EdU) was prepared at a concentration of 
60 mg/ml in sterile saline. IP injections of EdU (cat #. E10187, Invitrogen, Carlsbad, CA) 
resulted in a final effective delivery of 160 mg/Kg. Due to money constrains, animals in 
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all groups were injected only once with EdU, 4 days before intralipid or propofol infusion 
(Figure 16). 
 Propofol anesthesia: a cohort of rats was randomly assigned to four different 
groups breathing air (n=10 per group): young rats that received 35 mg/kg/hr of propofol 
or 10% intralipid (control) for 3 hrs, and aged rats that received 35 mg/kg/hr of propofol 
or 10% intralipid for 3 hours. Unanesthetized rats were placed in a restrainer and a tail 
vein catheter was implanted and attached to a syringe pump (model 11 Plus; Harvard 
Apparatus). Propofol (Disoprivan; AstraZeneca) or 10 % intralipid (Fresenius Kabi; 
Sweden) that served as control was continuously administered for 3 hours. Body 
temperature of rats was maintained at 37°C with a thermostatically controlled heating 
pad. 
 Measurement of Perioperiative Parameters during propofol anesthesia: rectal 
temperature was monitored using a thermalet-monitoring thermometer (Physitemp 
instrument Inc, Clifton, NJ, USA). Moreover, hemoglobin oxygen saturation (SpO2) and 
heart rate (HR) were recorded during anesthesia period using the SurgiVet multi 
parameter monitor (Smiths medical, Dublin, OH, USA). Diastolic, systolic and mean 
arterial pressures were measured every 30 minutes throughout the anesthesia period by 
tail cuff using the CODA non- invasive blood pressure system for rats (CODA2, Kent 
Scientific Corporation). 
 Tissue collection and processing: twenty-four hours after intralipid or propofol 
infusion, rats were deeply anesthetized with pentobarbital (50 mg/ Kg, i.p) and 
transcardially perfused with 100 ml saline followed by ice-cold 4% paraformaldehyde in 
0.1M PBS. Brains were removed, postfixed in the same fixative solution at 4°C 
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overnight, transferred to 20% sucrose in PBS until equilibrated, and then embedded in 
Tissue-Tek OCT before cryostat sectioning. Sagittal cryosections (30 µm thick) through 
the entire DG were collected serially, transferred to a cryoprotectant solution, and stored 
at -20°C until used. These sections were used to assess proliferation and phenotypic 
determination of nascent cells in the DG. All standard staining procedures were 
conducted on free-floating sections using every twelfth section for the entire 
hippocampus beginning with a random start and including sections before and after the 
hippocampus to ensure that the entire structure was sampled. 
 CldU and IdU Immunohistochemistry: for immunohistochemistry sections 
were washed three times for 10 min in PBS before being treated with 0.2N HCL for 10 
min at 37°C for DNA denature to facilitate antibody access, sections were then washed 
with borate buffer (pH 8.5), followed by three washes of PBS. Sections were then 
incubated in 5% normal goat serum and 0.25% Triton X-100 in PBS (PBS-TS) for 60 
min, and stained at 4°C. Detection of halogenated thymidine analogs was accomplished 
using rat anti-BrdU (Accurate cat# OBT-0030; clone BU1/75) at 1:250 for CldU and 
mouse anti-BrdU (Becton Dickinson cat# 347580; clone B44) at 1:500 for IdU. All 
secondary antibodies were used at 1:300 and were conjugated to the fluorophore 
Alexa594. 
 EdU labeling protocol: EdU labeling was performed using Click-iTTM EdU 
imaging kit cat # C10339 (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
protocol. This protocol is normally intended for use in cell culture, but it was adapted for 
histological staining of brain tissue. Sagittal cryosections (30 µm thick) were washed 
three times for 10 min in PBS. After washing twice with 3% bovine serum albumin 
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(BSA) in PBS the sections were permeablized with 0.5% Triton X-100 in PBS for 20 
min. The sections were washed twice with 3% BSA in PBS and then incubated with the 
Click-iTTM reaction buffer, CuSO4, Alexa Fluor 594 Azide, and the reaction buffer 
additive for 30 min while protected from light. The sections were washed one more time 
with 3% BSA in PBS. Sections were then mounted onto glass slides, and coverslipped 
with Vectashield mounting medium for fluorescence (cat# H-1000 Vector Laboratories, 
Burlingame, CA, USA). 
 Double immunohistochemistry for lineage markers: the phenotypes of CldU, 
IdU and EdU labeled cells were determined using double immunofluorescent staining. 
Antibodies against DCX, NeuN and S100β were used to detect immature neurons, mature 
neurons and astrocytes, respectively. DNA denaturation, followed by incubation of the 
primary antibodies for CldU and IdU was performed as described above, together with a 
rabbit polyclonal goat antibody raised against human DCX (1:200 cat# 4604 Cell 
Signaling technology, Inc. Danvers, MA, USA) was used in an antibody cocktail with the 
IdU antibody, a mouse monoclonal antibody against neuronal nuclei, NeuN (MAB377 
Millipore, Billerica, MA, USA) was used at a concentration of 1:500 in an antibody 
cocktail with the CldU antibody, and a rabbit monoclonal goat antibody raised against 
S100β (ab52642 abcam, Cambridge, MA, USA) was used at a concentration of 1:3000 in 
an antibody cocktail with CldU and IdU. 
 For double labeling of EdU/DCX and EdU/S100β EdU staining was performed 
first, followed by incubation in with a rabbit polyclonal goat antibody against human 
DCX or in and a rabbit monoclonal goat antibody against S100β, respectively. 
 Ki67 Immunohistochemistry: Ki67 is expressed in cells G1 through M phase of 
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the cell cycle(Scholzen and Gerdes 2000). For detection of Ki67, sections were pretreated 
with 1X Saline-Sodium Citrate (SSC) at 80°C for 40 minutes. Subsequently, endogenous 
peroxidase activity was quenched with 0.6% H2O2 solution in PBS for 20 min. Sections 
were blocked for 1 hour in 2% normal goat serum and 0.25% Triton X-100 in PBS (PBS-
TS). Sections were incubated overnight at 4°C with a rabbit polyclonal antibody against 
human Ki67 (NCL-Ki67p; Novocastra Laboratories/Vision BioSystems, Newcastle upon 
Tyne, UK) at a dilution of 1:2000 in PBS-TS. The following day, sections were washed 
in PBS, incubated for one hour in biotinylated secondary antibody (goat anti-rabbit IgG 
rat adsorbed 1:1000; BA-1000 Vector Laboratories, Burlingame, CA) in PBS-TS, and 
washed in PBS before incubation for 1 hour in avidin-biotin substrate (ABC kit cat no. 
PK-6100, Vector Laboratories, Burlingame, CA). Sections were washed in PBS for 10 
minutes and reacted with 3,3´- diaminobenzidine tetrahydrochloride (DAB) solution (cat 
no.1856090, Thermo Scientific, Rockford, IL). Sections were then mounted onto glass 
slides, dehydrated, and coverslipped with mounting medium (Cytoseal 60,Stephens 
Scientific, Riverdale). 
 Tunel assay protocol: in order identify which of the labeled cells were dying, the 
in situ cell death detection kit, Fluorescein (cat no. 11684795910, Roche, Mannheim, 
Germany) was used according to the manufacturer's instructions. Sections were incubated 
with 3% bovine serum albumin in 0.1 mol/L Tris-HCL (pH 7.5) for 30 mins followed by 
50 µL of TUNEL reaction mixture on each sample for 60 mins at 37°C. After washing, 
slides were incubated with 0.3% H2O2 in methanol for 10 mins, followed by 3% bovine 
serum albumin in 0.1 mol/L Tris-HCL (pH 7.5) for 30 mins at room temperature. 
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Incubation with peroxidase-conjugated anti-fluorescein (diluted 1:5) at 37°C for 30 mins 
was performed. 
 Microscopy and cell counting: unbiased stereological methods were used to 
estimate the numbers of positive labeled cells (+labeled cells) in the subgranular zone of 
the DG. Twelve equally spaced sections throughout the medial-lateral extent of the DG 
were collected. Because +labeled cells are a rare event, the number of +labeled cells in 
each DG examined was summed for individual animals and the sum from each animal 
was then multiplied by the section spacing to estimate the total number of +labeled cells 
(Mouton 2002)These data were then used to calculate group means for estimates of total 
+labeled cells. Labeled cells that were greater than 1 cell diameter away from the 
subgranular layer were not included in the count 
 Sections were imaged on an Olympus FV1000 MPE multiphoton laser scanning 
microscope with four laser sources: 405 Diode, multi-line Argon (for Alexa 488), green 
HeNe (for Alexa 594), and red HeNe was used for all immunofluorescence 
photomicrographs. When quantification of percentage of positive cells was determined, Z 
stacks were created at 1 µm intervals throughout the 30 µm of the sections with a guard 
region of 2µm excluded form top and bottom of the Z stack. The Z stacks were rotated in 
all planes to verify double labeling. Images of positive staining were adjusted to make 
optimal use of the dynamic range of detection.  
 Statistical analyses: data are presented as mean ± SEM. Analysis of variance 
(ANOVA) with Tukeys post hoc or a t-test was used to compare the differences from the 
control group. P-values less than 0.05 were considered statistically significant, the 
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significant testing was one-tailed and GraphPad Prism version 5.00 for Mac (GraphPad 
Software, San Diego California USA, www.graphpad.com) was used to analyze the data.  
 
Results 
 Physiological parameter during propofol anesthesia: rectal temperature was 
recorded every 30 mins after propofol induction in young (n=8) and aged (n=8) rats. 
Temperature was stable through the anesthesia period in both young and aged rats, with 
temperature in the aged rats being approximately 1°C less than in young rats. Systolic, 
diastolic and mean arterial blood pressure (mmHg) were recorded every 30 mins after 
propofol induction in young and aged rats. The blood pressure was stable during the 
exposure with a small decline in the aged rats as compared to the young rats. Moreover, 
hemoglobin oxygen saturation and heart rate were also recorded every 30 minutes after 
propofol induction in young and aged rats. Data are shown as mean ± SEM (Figure 17).  
 Postnatal proliferation in the Dentate Gyrus, as assessed by the Ki67 marker, 
is unaffected by propofol exposure: the effects of propofol anesthesia (35 mg/Kg/hr for 3 
hours) on neuronal cell proliferation in the SGZ in young (3 month old) and aged (20 month-old) 
F344 rats was determined by analyzing Ki-67 labeling, 24 hours after exposure. Figure 18B 
shows that Ki67 positive cells in both young and aged rats were primarily located on the border 
of the granule cell layer. Propofol does not appear to have an effect on newborn cells generated 
during the 24 hours after exposure (Figure 18A). The results were subjected to a 2 (age: young, 
aged) X 2 (treatment: control, propofol) factorial ANOVA. There was a significant effect of age 
(F (3, 7) = 28.93, p <0.0001), but no significant effect of treatment (F (3, 7) = 0.98, p = 0.47). 
Propofol anesthesia did not result in a statistically significant effect in the young (p= 0.130) nor in 
the aged rats (p=0.400).  
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 Nascent cells undergoing differentiation in the DG of young, but not aged 
rats, are affected by propofol anesthesia: we look at the number of newborn cells 
undergoing differentiation at the time of propofol infusion by estimating the number of 
EdU positive cells. And determined the phenotype of these newly born cells using double 
labeling of EdU and the immature neuronal marker DCX (Figure 19C) and EdU and the 
astrocytic marker S100β (Figure 19A-B). The results were subject to a 2 (age: young, 
aged) X 2 (treatment: intralipid, propofol) factorial ANOVA. There was a significant 
effect of age (F (2,11)= 16.61, p<0.0001), and a significant effect of treatment (F (2,11)= 
6.61, p< 0.05). Propofol anesthesia resulted in a statistically significant decrease in the 
number of EdU+ cells (*p=0.034), in the number of EdU+/DCX+ cells (**p=0.023), but 
not in the number of EdU+/S100B cells (***p=0.260) 
 Nascent cells undergoing migration in the DG are altered by propofol 
anesthesia in young, but not in aged rats: we counted at the number of newborn cells 
undergoing migration at the time of the propofol, anesthesia by estimating the number of 
IdU positive cells. And determined the phenotype of these newly born cells using double 
labeling of IdU and the immature neuronal marker DCX (Figure 20C) and IdU and the 
astrocytic marker S100β (Figure 20D). The results were subject to a 2 (age: young, aged) 
X 2 (treatment: intralipid, propofol) factorial ANOVA. There was a significant effect of 
age (F (7,11)= 73.02, p<0.0001), and a significant effect of treatment (F (7,11)= 1.47, 
p<0.05). Propofol significantly decreased the number of IdU+ cells (*p=0.034), 
IdU+/DCX+ cells (**p=0.047), and increased the number of IdU+/S100β+ cells 
(***p<0.0001) in the DG of young, but not aged rats. 
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 Nascent cells undergoing maturation, in the DG of young and aged rats, are 
unaffected by propofol anesthesia: we estimated the number of newborn cells 
undergoing synaptic integration at the time of propofol exposure by estimating the 
number of CldU positive cells, and determined the phenotype of these newly born cells 
(Figure 21A-B) using double labeling of: CldU and the mature neuronal marker NeuN 
(Figure 21C), and CldU and the astrocytic marker S100β. There was a significant effect 
of age (F (7,11)= 52.65, p<0.0001), but not a significant effect of treatment (F (7,11)= 1.94, 
p=0.07). 
 Cell death in the DG after propofol anesthesia: cell death positive label in the 
DG was assessed by the DNA strand breaks (TUNEL Assay) in young and aged rats 24 
hours after propofol anesthesia (Figure 22). The results were subject to a 2 (age: young, 
aged) X 2 (treatment: intralipid, propofol) factorial ANOVA. There was not s significant 
effect of age (F (2,3)= 3.53, p=0.08), and no significant effect of treatment (F (2,3)= 0.42, 
p=0.67). Propofol anesthesia did not result in a statistically significant effect in the young 
(p=0.19) nor in the aged rats (p=0.12). 
 
Discussion 
 The findings of this study are: first, the expected age-related decrease in the rate 
of postnatal neurogenesis in aged as compared to young rats. Second, the age-dependent 
effects of propofol on the young, but not on the aged rat brain. Third, the stage-dependent 
effect of propofol, on nascent cells undergoing differentiation, migration and 
axon/dendrite targeting, but not on nascent cells undergoing maturation and synaptic 
integration. And lastly, it was found that the cognitive dysfunction experienced by some 
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patients after anesthesia and which may be explained by an anesthetic-induced alteration 
of postnatal neurogenesis appears to be agent-dependent, with isoflurane being 
particularly harmful to the aged brain, and propofol being particularly harmful to the 
young brain. 
 Propofol anesthesia has a specific effect on the young brain: human and 
animal data suggest that propofol is harmful to developing neurons in the young brain 
that result in cognitive sequelae (Takamatsu et al. 2005; Vutskits 2005; Mellon et al. 
2007; Meyer et al. 2010). A study that examines neurogenesis as an explanation for 
cognitive dysfunction, did not find and impairment of cognitive function in eighteen-
month old rats exposed to two hours of propofol anesthesia (Lee et al. 2008). However, 
they did not examine the effect of propofol on the entire process of postnatal 
neurogenesis. In this study, it was found that propofol particularly affects nascent cells in 
the DG of young rats, but not aged rats. The neurogenic niche is regulated by signaling 
from growth factors, trophic factors and neurotransmitters among others (Palmer et al. 
2000; Taupin 2006), during development many of these signals are altered, and the 
neurogenic process itself its occurring at a higher rate. For all this and more, the young 
brain is particularly vulnerable to insults, in this case particularly vulnerable to anesthetic 
toxicity. 
 Nascent cells undergoing differentiation and migration, in the DG of young 
rats, at the time of anesthetic exposure are particularly affected by propofol: 
evidence suggesting that propofol may be toxic to developing neurons (Spahr-Schopfer et 
al. 2000; Fredriksson et al. 2007), and increasing clinical and laboratory data suggest an 
anesthetic induced impairment of cognitive function (Loepke and Soriano 2008) is 
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currently raising concerns in pediatric anesthesia. A study of the effects of propofol on 
neuronal structure and neurocognitive performance in mice suggests that propofol 
increases neurodegeneration, leading to adult, behavioral, and learning impairment in a 
dose dependent manner (Fredriksson et al. 2007). Moreover, an in vitro study of neuronal 
cell cultures from immature chicks and rats showed that supraclinical doses of propofol 
induce neuronal cell death in dissociated cell culture models, but it fails to demonstrate 
neurotoxic effects in organotypic slice culture (Spahr-Schopfer et al. 2000). Even though, 
no prospective studies have examined the propofol effects on neuronal structure and 
neurocognitive outcome in children, several case reports detail short-term neurological 
abnormalities. In this study, a similar effect of propofol on the brain of young rats was 
found. This effect was found to be specific to the nascent cells undergoing the first stages 
of postnatal neurogenesis suggesting a specific susceptibility of immature nascent cells in 
the DG.  
 Nascent cells in the DG of young and aged rats seem to be affected by 
anesthetics in agent-dependent manner: this study shows that a anesthetic, i.e. 
propofol, produces cognitive effects on one age population, i.e. young, whereas the other 
does not, i.e. isoflurane, as previously reported. The most obvious explanation is these 
two anesthetics have different receptor mechanisms of action. Propofol inhibits synaptic 
transmission primarily by enhancing GABA receptors while having smaller effects on 
NMDA receptors. On the other hand, isoflurane acts less selectively on GABA and 
NMDA receptors. These differences in affinity for specific receptors are also associated 
with differences in hippocampal electrophysiology, with isoflurane blocking induction of 
long-term potentiation (LTP) and long-term depression (LTD) (Stevens 1998), while 
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propofol only partially inhibits LTP and has no effect on LTD (Nagashima et al. 2005). 
Consequently, it appears that there are important functional differences among 
anesthetics with respect to memory process. Due to these inherent differences in the 
molecular actions, not all agents that produce general anesthesia result in cognitive 
impairments.  
 In conclusion, these results add to the growing body of evidence indicating that 
exposure to general anesthetics early and late in life cause cognitive dysfunction, and 
suggest that vulnerability to these deleterious effects may be age and agent dependent. 
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 Figure 16. Experimental design. Rats in all groups were injected 21, 8, and 4 
days before propofol exposure, with CldU, IdU and EdU respectively. In order to study 
the effects of propofol on integration, maturation and differentiation of neuronal cell 
proliferation in the DG of young and aged rats  
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 Figure 17. Rats Physiological Parameters during Propofol Exposure (A) 
Rectal temperature was recorded every 30 mins after propofol induction in young (n=8) 
and aged (n=8) rats. Temperature was stable through the anesthesia period in both young 
and aged rats, with temperature in the aged rats being approximately 1°C less than in 
young rats. (B) Systolic, diastolic and mean arterial blood pressure (mmHg) were 
recorded every 30 mins after propofol induction in young and aged rats. The blood 
pressure was stable during the exposure with a small decline in the aged rats as compared 
to the young rats. (C) Hemoglobin oxygen saturation and heart rate were also recorded 
every 30 minutes after propofol induction in young and aged rats. Data are shown as 
mean ± SEM. 
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 Figure 18. Neural Progenitor Cell Proliferation is Unaffected by Propofol 
Anesthesia (A) Shows the estimated number of Ki67 positive cells in the DG 24 hours 
after propofol anesthesia in young and aged rats. The results were subjected to a 2 (age: 
young, aged) X 2 (treatment: control, propofol) factorial ANOVA. There was a 
significant effect of age (F (3, 7) = 28.93, p <0.0001), but no significant effect of 
treatment (F (3, 7) = 0.98, p = 0.47). Propofol anesthesia did not result in a statistically 
significant effect in the young (p= 0.130) nor in the aged rats (p=0.400). (B) 
Immunohistochemical staining for Ki67 positive cells (20X, upper image) and (40X, 
lower image) in DG 24 hours after propofol exposure in young and aged rats.      
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Figure 19. The 
number and fate of 4 
days-old nascent 
cells in the DG are 
altered by propofol 
anesthesia in young, 
but not in aged rats 
(A and B)  
(A) Quantification of 
EdU+ cells (right 
column), EdU+/DCX+ 
cells (middle column), 
and EdU+/S100β+ 
cells (left column) in 
the DG of young rats 
after propofol. (B) 
Quantification of 
EdU+ cells (right 
column), EdU+/DCX+ 
cells (middle column), 
and EdU+/S100β+ 
cells (left column) in 
the DG of aged rats 
after propofol. The 
results were subject to 
a 2 (age: young, aged) 
X 2 (treatment: 
intralipid, propofol) 
factorial ANOVA. 
There was a 
significant effect of 
age (F  (2,11)= 16.61, 
p<0.0001), and a 
significant effect of 
treatment (F (2,11)= 6.61, p< 0.05). Propofol anesthesia resulted in a statistically 
significant decrease in the number of EdU+ cells (*p=0.034), in the number of 
EdU+/DCX+ cells (**p=0.023), but not in the number of EdU+/S100B cells (p=0.260) 
(C) Confocal plane of the same cell, showing co-localization of EdU+ (red), DCX+ 
(green) and EdU+/DCX+ (orange) indicating differentiation into neuronal phenotype. 
Newly formed double-labeled cells were visualized using concofal microscopy in an 
orthogonal projection composed of 25 optical z-planes (0.5mm thick).  
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Figure 20. Cells undergoing maturation in the DG at 8 days after birth are altered by 
propofol anesthesia in young, but not in aged rats. (A and B). Quantification of IdU+ cells 
(right column), IdU+/DCX+ cells (middle column), and IdU+/S100β+ cells (left column) in the 
DG of young rats (A) and aged rats (B) after propofol. The results were subject to a 2 (age: 
young, aged) X 2 (treatment: intralipid, propofol) factorial ANOVA. There was a significant 
effect of age (F  (7,11)= 73.02, p<0.0001), and a significant effect of treatment (F (7,11)= 1.47, 
p<0.05). Propofol significantly decreased the number of IdU+ cells (*p=0.034), and IdU+/DCX+ 
cells (**p=0.047), but increased IdU+/S100β+ cells (***p<0.0001) in the DG of young, but not 
aged rats (C) Confocal plane of the same cells, showing co-localization of IdU+ (red), DCX+ 
(green) and IdU+/DCX+ (orange) indicating neuronal phenotype. (D) Confocal plane of the same 
cell, showing co-localization of IdU+ (red), S100β+ (green) and IdU+/S100β+ (orange) 
indicating astrocytic phenotype. Double-labeled cells were visualized using concofal microscopy 
in an orthogonal projection composed of 25 optical z-planes (0.5mm thick). 
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Figure 21. Propofol anesthesia does not alter nascent cells that underwent 
maturation and Starting to integrate in the DG of young or aged rats Quantification 
of CldU+ cells (right column), CldU+/NeuN+ cells (middle column), and CldU+/S100β+ 
cells (left column) in the DG of young (A) and aged (B) rats after propofol. The results 
were subject to a 2 (age: young, aged) X 2 (treatment: intralipid, propofol) factorial 
ANOVA. There was a significant effect of age (F  (7,11)= 52.65, p<0.0001), but not a 
significant effect of treatment (F (7,11)= 1.94, p=0.07). (C) Confocal plane of the same 
cell, showing co-localization of CldU+ (green), NeuN+ (red) and CldU+/NeuN+ (orange) 
indicating neuronal phenotype. Newly formed double-labeled cells undergoing 
integration were visualized using concofal microscopy in an orthogonal projection 
composed of 25 optical z-planes (0.5mm thick).  
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 Figure 22. Cell death in the DG after propofol anesthesia. Quantification of 
the TUNEL+ labeling in the DG of young and aged rats, 24 hours after propofol. 
Propofol anesthesia has no effect on cell death in the DG of young or aged rats. The 
results were subject to a 2 (age: young, aged) X 2 (treatment: intralipid, propofol) 
factorial ANOVA. There was not s significant effect of age (F  (2,3)= 3.53, p=0.08), and 
no significant effect of treatment (F (2,3)= 0.42, p=0.67). Propofol anesthesia did not result 
in a statistically significant effect in the young (p=0.19) nor in the aged rats (p=0.12). 
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CONCLUSIONS:  
ANESTHETIC-INDUCED ALTERATION OF POSTNATAL NEUROGENESIS, A 
POSSIBLE CAUSE OF THE COGNITIVE DYSFUNCTION OBSERVED IN 
SOME PEDIATRIC AND GERIATRIC PATIENTS 
 
Introduction 
 The use of general anesthetics involving millions of pediatric and geriatric 
patients is widespread today. Emerging, clinical and laboratory findings suggest that 
general anesthesia early or late in life may cause impairment of cognitive function, the 
mechanism of which is still unknown (Dodds and Allison 1998; Culley et al. 2003; 
Stratmann 2006; Loepke and Soriano 2008). Because cognitive function is in part 
dependent on postnatal neurogenesis (Shors et al. 2001; Snyder et al. 2005; Coras et al. 
2010). It is reasonable to infer that an anesthetic-induced alteration of postnatal 
neurogenesis may, in part, explain the cognitive impairment observed after anesthesia in 
pediatric and geriatric patients. This dissertation discusses the effects of two different 
kinds of general anesthetics, isoflurane and propofol, on postnatal neurogenesis. First, it 
focuses on their effects on the entire process of postnatal neurogenesis. Second, it 
examines these effects on the two populations that seem to be more vulnerable to 
anesthetic-induced cognitive impairment. Third, it studies two kinds of anesthetics that 
are widely used, but have different mechanisms of action. 
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The process of postnatal neurogenesis 
 One of the major objectives of this dissertation is to provide an analysis of the 
effects of isoflurane and propofol anesthesia on the entire process of postnatal 
neurogenesis, which is a complex process that involves multiple stages. Postnatal 
neurogenesis is a multistep process that involves a series of developmental stages; the 
final result is that few nascent cells are added to the existing hippocampal neuronal 
circuitry. The neurogenic process starts with proliferation of the neural/stem progenitor 
cells producing a pool of immature cells, the majority of which will become neurons if 
they survive. The percentage of surviving neurons varies depending on the strain of 
animal used; it can be as great as 75% or as little as 25% of the proliferating cells  
(Kempermann et al., 1997c). Subsequently, nascent cells that had differentiated and 
survived go through a migratory stage that occurs while the cells are becoming 
functionally mature (Kempermann et al., 2003b). Nascent neurons become 
morphologically and physiologically fully mature 6 to 8 weeks after birth in the young 
rodent (van Praag et al., 2002; Esposito et al., 2005; Zhao et al., 2006; Toni et al., 2008).  
 Alteration of one or more stages of postnatal neurogenesis may explain the 
cognitive dysfunction observed in some pediatric and geriatric patients following general 
anesthesia. Indeed in this dissertation, by examining the effects of isoflurane and propofol 
on nascent cell number and phenotype at each developmental stage of neurogenesis an 
anesthetic-induced alteration of one or more developmental stages was found. A 
summary of the results is presented on figure 23. Cognitive function following anesthesia 
was assessed in the first portion of this dissertation. However, emerging data show that 
newly generated neurons in the dentate gyrus of the hippocampus play a significant role 
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in spatial learning and memory, and that the reduction in the number of these cells 
impairs cognitive function (Shors et al. 2001; Dupret et al. 2008; Zhao et al. 2008; Coras 
et al. 2010). In addition, the role of postnatal neurogenesis in hippocampal dependent 
learning and memory appears to be affected by different factors. For instance, 
environmental enrichment (Kempermann et al. 1997) and exercise (van Praag et al. 1999) 
results in increased neurogenesis. Conversely, stress (Mirescu et al. 2004), irradiation 
(Tada et al. 2000; Mizumatsu et al. 2003) and age (Klempin and Kempermann 2007; 
Shruster et al. 2010) decrease neurogenesis and impair different aspects of hippocampal 
dependent memory (Dupret et al. 2008). For that reason, it is reasonable to hypothesize 
that general anesthetics may have an effect on cognition.  
Age-dependent vulnerability to anesthetic-induced cognitive dysfunction 
 Impairment of cognitive function in pediatric and geriatric patients who received 
sedation or anesthesia has raised concern regarding their relevance and potential 
implications for the practice of anesthesia. This dissertation particularly focuses on the 
effects of anesthetics on these two populations. Previous studies suggest an age-
dependent vulnerability to the development of cognitive dysfunction following anesthesia 
(Culley et al. 2003; Jevtovic-Todorovic et al. 2003; Culley et al. 2004; Stratmann 2006; 
Meyer et al. 2010). Certainly, the data presented in this dissertation supports those 
findings. The hippocampus appears to be particularly susceptible to general anesthetics, 
during development and aging. Neurogenesis, gliogenesis and synaptogenesis occur at a 
high rate during development. During aging there is a decline in cell proliferation in the 
SGL, which is associated with decline in hippocampal-dependent spatial memory (Coras 
et al. 2010). Despite an age-related reduction in the formation of new hippocampal 
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neurons, the neurons that are added appear functionally equivalent to those in young 
brain. This suggests, that neurogenesis in the aged brain is not aberrant, but simply down 
regulated, with reduced cell proliferation and retarded neuronal maturation (Rao et al. 
2005).  
 This dissertation examined the two previously mentioned age groups, because 
they are the two populations that show cognitive decline. Moreover, neurogenesis 
particularly in these two populations occurs at a different rate than in other populations. 
During development and aging neurogenesis occurs at a higher and lower rate 
respectively. In addition to the age-dependent effect suggested by the results on this 
dissertation, an agent-dependent effect was also found. Isoflurane appears to be harmful 
to the aged but not the young brain. On the other hand, propofol seems to be harmful to 
the young but not the aged brain. 
Agent-dependent effects on postnatal neurogenesis 
 The final objective of this dissertation was to identify the effects of two kinds of 
general anesthetics. As reported here, one general anesthetic, isoflurane, produces cellular 
effects in one age group, aged animals, while the other, propofol, does not. A possible 
explanation is that these general anesthetics have different receptor mechanisms of 
action. Isoflurane inhibits synaptic transmission in the central nervous system by acting 
on various systems including those implicated in γ-aminobutyric acid (GABA), and N-
methyl-d-aspartate (NMDA) receptors (Orser et al. 1994; Solt and Forman 2007). 
Propofol acts primarily by enhancing GABA, and having smaller effects on NMDA 
receptors (Nishikawa and MacIver 2000). These differences in receptor affinity are also 
associated with differences in hippocampal electrophysiology, with isoflurane blocking 
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induction of long-term potentiation (LTP) and long-term depression (LTD) (Stevens 
1998), while propofol only partially inhibits LTP and has no effect on LTD (Nagashima 
et al. 2005). 
 Another factor, is the regulation of postnatal neurogenesis by neurotransmitters 
(Ge et al. 2007). For instance, GABA causes depolarization of immature neurons 
(Nagashima et al. 2005; Bordey 2006; Platel et al. 2007). Moreover, GABA antagonism 
increases proliferation of neural progenitor cells, whereas GABA agonism exhibits the 
opposite effects (Tozuka et al. 2005). Interestingly, a lack of GABA induced 
depolarization in newborn neurons leads to significant defects in their dendritic 
development and synapse formation. Taken together, GABA-induced depolarization 
promotes the differentiation, maturation, and functional integration of newly generated 
cells in the postnatal dentate gyrus (DG). Similarly glutamate release from astrocytes and 
neurons may activate the immature neuron receptors and regulate the development of 
immature neurons (Montana et al. 2004). Moreover, recent studies of electrophysiology 
have shown that newborn neurons in the DG begin to receive functional glutamatergic 
inputs two weeks after they are born (Esposito et al 2005, GE et al 2006, Carleton et al 
2003), and NMDA receptors antagonists have been shown to increase the number of new 
immature neurons (Tashiro et al 2006).  Thus, Glutamate has a direct regulatory role on 
the stages of postnatal neurogenesis. 
 Consequently, GABA and NMDA signaling are neurogenic trophic factors and 
excessive stimulation or under stimulation of them in the young or aged brain may cause 
behavioral consequences by altering neural connectivity (Manent et al. 2007). So it 
appears that there are important functional differences among anesthetics with respect to 
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memory process, and due to these inherent differences in the molecular actions, not all 
agents that produce general anesthesia result in cognitive impairment in a particular age 
group 
Conclusion 
 For many years, general anesthetics have been considered to be safe since there 
were not reports indicating otherwise. However, emerging clinical and laboratory data 
suggest that pediatric and geriatric patients are at risk of cognitive dysfunction following 
general anesthesia. Current studies and this dissertation suggest that an anesthetic-
induced alteration of postnatal neurogenesis may result in later impairment of cognitive 
function. Because neurogenesis is particularly vulnerable during developing and aging, 
the two main affected groups are at the extremes of age. The use of anesthetics is a 
necessity that cannot be avoided in pediatric and geriatric patients when life-threatening 
conditions require surgery. Therefore, it is urgent that we improve our understanding of 
the mechanisms underlying the cognitive function impairment induced by anesthetics.  
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         Figure 23. Summary diagram of the results presented in this dissertation 
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